oncobiologics inc  product pipeline review    compare about us  contact us home research category publisher list custom research cart compare research category user guide policies contact us about us site map home  market research report  pharmaceutical  pharmaceutical companies market research report oncobiologics inc  product pipeline review   published by global markets direct product code  published december   content info  pages price usd  pdf by email single user license usd  pdf by email site license usd  pdf by email global license oncobiologics inc  product pipeline review   published december   content info  pages description summary global markets directs oncobiologics inc  product pipeline review   provides an overview of the oncobiologics incs pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of oncobiologics incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope the report provides brief overview of oncobiologics inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of oncobiologics incs human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement latest news and deals relating to the oncobiologics incs pipeline products reasons to buy evaluate oncobiologics incs strategic position with total access to detailed information on its product pipeline assess the growth potential of oncobiologics inc in its therapy areas of focus identify new drug targets and therapeutic classes in the oncobiologics incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of oncobiologics inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of oncobiologics inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of oncobiologics inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contents product code gmdhccdbtable of contents table of contents list of tables list of figures oncobiologics inc snapshot oncobiologics inc overview key information key facts oncobiologics inc  research and development overview key therapeutic areas oncobiologics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy oncobiologics inc  pipeline products glance oncobiologics inc  clinical stage pipeline products phase i productscombination treatment modalities oncobiologics inc  early stage pipeline products preclinical productscombination treatment modalities oncobiologics inc  drug profiles adalimumab biosimilar product description mechanism of action rd progress bevacizumab biosimilar product description mechanism of action rd progress cetuximab biosimilar product description mechanism of action rd progress denosumab biosimilar product description mechanism of action rd progress golimumab biosimilar product description mechanism of action rd progress tocilizumab biosimilar product description mechanism of action rd progress trastuzumab biosimilar product description mechanism of action rd progress ustekinumab biosimilar product description mechanism of action rd progress oncobiologics inc  pipeline analysis oncobiologics inc  pipeline products by target oncobiologics inc  pipeline products by route of administration oncobiologics inc  pipeline products by molecule type oncobiologics inc  pipeline products by mechanism of action oncobiologics inc  recent pipeline updates oncobiologics inc  dormant projects oncobiologics inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tables oncobiologics inc key information oncobiologics inc key facts oncobiologics inc  pipeline by indication  oncobiologics inc  pipeline by stage of development  oncobiologics inc  monotherapy products in pipeline  oncobiologics inc  phase i  oncobiologics inc  preclinical  oncobiologics inc  pipeline by target  oncobiologics inc  pipeline by route of administration  oncobiologics inc  pipeline by molecule type  oncobiologics inc  pipeline products by mechanism of action  oncobiologics inc  recent pipeline updates  oncobiologics inc  dormant developmental projects list of figures oncobiologics inc  pipeline by top  indication  oncobiologics inc  pipeline by stage of development  oncobiologics inc  monotherapy products in pipeline  oncobiologics inc  pipeline by top  target  oncobiologics inc  pipeline by top  route of administration  oncobiologics inc  pipeline by top  molecule type  oncobiologics inc  pipeline products by top  mechanism of action  phone intl  tollfreeus  europe  asia  new for   gii now purchases any market research reports from any publishers for you with noextra cost contact us for more details faq delivery time user license payment options compare multiple reports about contact user guide policies site map  copyright  global information inc all rights reserved oncobiologics  targeting healthy outcomes oncobiologics home  careers  partner  news  investors  contact about about oncobiologicsboard of directorssenior management biosymphony model biosymphony modelbiosimilars pipeline development platform cmc developmentregulatory  clinical developmentfacility tour manufacturing manufacturing platformgmp manufacturing facility tour publications in the news oncobiologics to present at the world biosimilar congress more oncobiologics the most interesting biotech at jpmmore understanding biosimilars despite how far we have come there is still ample room to growmore how to prepare your biosimilar company for interchangeabilitymore interchangeable would be game changer for humira competitionmore  what we do oncobiologics is a clinical stage biopharmaceutical company focused on identifying developing manufacturing and commercializing complex biosimilar therapeutics our current focus is on technically challenging and commercially attractive monoclonal antibodies mabs in the disease areas of immunology and oncology our strategy is to costeffectively develop these biosimilars on an accelerated timeline which is fundamental to our success and we believe positions us to be a leading biosimilar company we have leveraged our team’s biopharmaceutical expertise to establish fully integrated inhouse development and manufacturing capabilities which we refer to as our biosymphony™ platform oncobiologics’ platform addresses the numerous complex technical and regulatory challenges in developing and commercializing mab biosimilars and was designed to provide significant pricing flexibility since inception we have advanced two product candidates into clinical trials ons a phase ready biosimilar to adalimumab humira® and ons a phase ready biosimilar to bevacizumab avastin® additionally we have identified multiple other biosimilar product candidates including six that are in active preclinical development one of which is expected to be ready to enter clinical trials in more  our pipeline view full size  company highlights ons humira® biosimilar and ons avastin® biosimilar ready to enter phase  clinical study eight complex biosimilars currently in active pipeline biosymphony™ a unique approach to biosimilars development and commercialization synthesizing development manufacturing regulatory and program management expertise with bestinclass global clinical development and commercial partners rigorous engagement of orthogonal analytics to demonstrate high biosimilarity of complex mabs an integrated development and manufacturing engine capable of generating two inds per year led by a team of leading scientists and engineers from the world’s top biopharmaceutical companies working in the agile unencumbered environment of a startup  sq ft facility in cranbury nj and expanding video a brief introduction to oncobiologics   join oncobiologics oncobiologics is a dynamic inspiring workplace where we seek bestinclass candidates to join our existing team of renowned specialists to learn more about opportunities with our team please visit our careers page more    oncobiologics inc clarke drive cranbury nj  usainfooncobiologicscom about careers oncobiologics  working at oncobiologics oncobiologics home  careers  partner  news  investors  contact about about oncobiologicsboard of directorssenior management biosymphony model biosymphony modelbiosimilars pipeline development platform cmc developmentregulatory  clinical developmentfacility tour manufacturing manufacturing platformgmp manufacturing facility tour publications working at oncobiologicscore valuescurrent job postings apply for a position working at oncobiologics started by a nucleus of accomplished pharma industry scientists and engineers oncobiologics represents a workplace where talented individuals come together to share their energy knowledge and experience in pursuit of common goals  the oncobiologics team is passionate about solving difficult medical problems and is committed to working in an open collaborative environment to make that happen  as the company grows there is a strong commitment to sustaining a vibrant entrepreneurial culture learn about our core values oncobiologics offers competitive compensation and benefit packages including medical vacation k incentive plans and others we invite you to review our open positions to discover if we have a current need for your skills  we also invite you to return periodically as our job postings are updated frequently   oncobiologics inc clarke drive cranbury nj  usainfooncobiologicscom about careers oncobiologics  the oncobiologics team oncobiologics home  careers  partner  news  investors  contact about about oncobiologicsboard of directorssenior management biosymphony model biosymphony modelbiosimilars pipeline development platform cmc developmentregulatory  clinical developmentfacility tour manufacturing manufacturing platformgmp manufacturing facility tour publications about oncobiologicsboard of directorssenior management the oncobiologics team we have assembled a team of industry veterans with decades of cumulative experience in biologics development and commercialization at such organizations as bristolmyers squibb company genentech inc hoffmanla roche nps pharmaceuticals inc and savient pharmaceuticals inc our leadership team has also been instrumental in obtaining global regulatory approval for multiple complex biologics at leading multinational biopharmaceutical companies our chief executive officer pankaj mohan phd served as a senior manager at eli lilly and company head of business operations and portfolio management of biologics process and product development at bristolmyers squibb company and director of bioprocess engineering at genentech inc in addition our scientific team has specific experience in process development for complex biologics protein manufacturing and analytical research and development which are essential components for the development and manufacturing of complex biosimilars oncobiologics combines the worldclass knowhow of leading discovery and development scientists with the agile innovative culture of a startup we have also developed an expert advisory team and partnerships with leading institutions to complement our capabilities   executive team   pankaj mohan phd   chairman ceo and president dr mohan has served as our president chief executive officer and as chairman and a member of our board of directors since january  prior to founding our company from may  to december  dr mohan served as head of business operations and portfolio management of biologics process and product development at bristolmyers squibb company from june  to may  dr mohan served as a director of bioprocess engineering at genentech inc a biotechnology company prior to that dr mohan served as a senior manager at eli lilly and company from may  to april  dr mohan served as assistant professor lecturerfellow at the advanced centre for biochemical engineering university college london london united kingdom from august  to december  dr mohan served as a scientific officer for the department of atomic energy for the government of india dr mohan has served as chairman and as a member of the board of directors of sonnet biotherapeutics inc since its inception in april  dr mohan received a phd in biochemical engineering from the school of chemical engineering university of birmingham birmingham united kingdom a masters in financial management from middlesex university business school london united kingdom an executive management program amp from fuqua school of business at duke university and a bachelor of chemical engineering from the indian institute of technology in roorkee india     kenneth m bahrt md facr   chief medical officer dr bahrt has served as our chief medical officer since june  prior to joining us from february  to may  dr bahrt served as the vice president of us medical affairs at nps pharmaceuticals inc a biopharmaceutical company from august  to january  dr bahrt served as senior vice president and chief medical officer at savient pharmaceuticals inc a biopharmaceutical company prior to that from september  to august  dr bahrt served as the therapeutic head of immunology medical affairs at genentech inc from july  to september  dr bahrt served as the global medical director for immunology at hoffmanla roche a swiss healthcare company prior to this dr bahrt held positions of increasing responsibility at bristol myers squibb pfizer and daiichi prior to joining the pharmaceutical industry dr bahrt was in clinical practice dr bahrt is a boardcertified internist and rheumatologist and a fellow of the american college of rheumatology dr bahrt received an md from hahnemann university and a bachelor’s degree in biology from muhlenberg college     lawrence a kenyon   chief financial officer mr kenyon has served as our chief financial officer and secretary since september  prior to that from february  to september  mr kenyon served as the chief financial officer of arno therapeutics inc a biopharmaceutical company focused on the development of therapeutics for cancer and other life threatening diseases and also as chief operating officer from july  to september  from december  to march  mr kenyon served as the interim president  chief executive officer chief financial officer and secretary of tamir biotechnology inc a publicly held biopharmaceutical company engaged in the development of oncology and antiinfective therapeutics prior to that from december  to july  mr kenyon was the executive vice president finance and commencing in march  the chief financial officer of par pharmaceutical companies inc a publicly held generic and branded specialty pharmaceutical company or par prior to joining par mr kenyon was the chief financial officer and secretary of alfacell corporation or alfacell from january  through february  and also served at various times during this period as alfacell’s executive vice president chief operating officer and president and was a member of alfacell’s board of directors from november  to april  prior to joining alfacell mr kenyon served as the executive vice president chief financial officer and corporate secretary at neopharm inc a publicly traded biopharmaceutical company from  to  mr kenyon received a ba in accounting from the university of wisconsinwhitewater and is a certified public accountant in illinois     stephen j mcandrew phd   senior vice president   business strategy  development dr mcandrew served initially as our vice president of business development from february  through march  and as our senior vice president business strategy  development since march  prior to joining us from march  to february  dr mcandrew served as the president of sjm biopharma consulting a biopharmaceutical consulting company from december  to march  dr mcandrew served as vice president of scientific commercial development at taconic biosciences inc a contract research and biotechnology company and from august  to december  dr mcandrew served as vice president of business development at caliper life sciences inc a biotechnology company prior to that from january  to august  dr mcandrew served as vice president of business development at xenogen biosciences corporation a provider of in vivo drug discovery services from january  to december  dr mcandrew served as vice president of pharmaceutical business development at lexicon pharmaceuticals inc a biopharmaceutical drug development company prior to that from march  to december  dr mcandrew served in various positions of increasing responsibility at bristolmyers squibb company including as director of biotechnology licensing dr mcandrew received a phd in cellular and molecular biology from ohio university an ms in molecular genetics from the state university of new york at albany and a bs from the state university of new york at oswego     scott a gangloff   senior vice president   process development and manufacturing mr gangloff has served as our senior vice president development  manufacturing since january  prior to that mr gangloff served as our vice president of process development and manufacturing from january  to january  and as our executive director of process development and manufacturing from may  to january  prior to joining us mr gangloff held various process engineering and manufacturing roles at bristolmyers squibb company serving as associate director process scaleup from january  to may  with oversight of clinical manufacturing manager of biologics scaleup facility from june  to january  and roles of increasing responsibility in cell culture development and process engineering from july  to june  from january  to july  mr gangloff served as process engineer at jacobs engineering group inc a technical professional services firm mr gangloff received a masters of engineering in chemical engineering from lehigh university and a bachelor of chemical engineering from villanova university     elizabeth a yamashita   vice president   regulatory affairs ms yamashita has served as our vice president of regulatory affairs since july  and prior to that our vice president of regulatory and clinical affairs since april  prior to joining us from october  to january  ms yamashita served as group vice president of regulatory affairs at savient pharmaceuticals inc a biopharmaceutical company and also as vice president cmc regulatory from june  to october  from may  to june  ms yamashita served as principal fellow cmc regulatory strategy and vice president regulatory cmc  operations at imclone systems inc a biopharmaceutical company prior to that ms yamashita was employed by bristolmyers squibb company for  years and from  to  ms yamashita served as the group director of global regulatory sciences cmc ms yamashita received a regulatory affairs certification from the regulatory affairs professional society and a bs in chemistry from the university of rochester     oncobiologics inc clarke drive cranbury nj  usainfooncobiologicscom about careers oncobiologics  contact oncobiologics home  careers  partner  news  investors  contact about about oncobiologicsboard of directorssenior management biosymphony model biosymphony modelbiosimilars pipeline development platform cmc developmentregulatory  clinical developmentfacility tour manufacturing manufacturing platformgmp manufacturing facility tour publications contact oncobiologics inc  clarke drive cranbury new jersey  usa   telephone   email  infooncobiologicscom   business development and partnering inquiries to inquire regarding partnership opportunities with oncobiologics please contact stephen j mcandrew phd senior vice president business development  ext    download directions to oncobiologics   oncobiologics inc clarke drive cranbury nj  usainfooncobiologicscom about careers oncobiologics  facility tour oncobiologics home  careers  partner  news  investors  contact about about oncobiologicsboard of directorssenior management biosymphony model biosymphony modelbiosimilars pipeline development platform cmc developmentregulatory  clinical developmentfacility tour manufacturing manufacturing platformgmp manufacturing facility tour publications cmc development rd facility overview regulatory  clinical developmentfacility tour cmb suite touranalytics  formulations tourprocess developmentgmp manufacturing facility tour please use the text links below to view the oncobiologics rd facilty  a complete floorplan of the integrated facility is provided below   lab  cell  molecular biology lab  analytics  formulation development lab  process development gmp manufacturing     oncobiologics inc clarke drive cranbury nj  usainfooncobiologicscom about careers oncobiologics  current job postings oncobiologics home  careers  partner  news  investors  contact about about oncobiologicsboard of directorssenior management biosymphony model biosymphony modelbiosimilars pipeline development platform cmc developmentregulatory  clinical developmentfacility tour manufacturing manufacturing platformgmp manufacturing facility tour publications working at oncobiologicscore valuescurrent job postings apply for a position current job postings current career opportunitiesto learn more please click view description for any of the positions listed below to apply for a position click on the title of the job postingthere are  job openings at oncobiologics incview descriptionjob title senior scientist  biophysical characterization analytical sciencesjob description qualification  skills a phd in biophysics biochemistry or equivalent filed with    years of industrial experience a ms in biophysics biochemistry or equivalent filed minimum  years of experience indepth understanding of biophysical characterization of proteins strong understanding of biophysical method development and qualification handson laboratory experience designing experiments with cd ftir mfi auc and dsc analysis for high order structure characterization and aggregation experience characterizing the structural variants of monoclonal antibodies is preferred good conceptual analytical problem solving and organizational skills – must be detailoriented well organized and able to work independently and be flexible with changing project timeline internal expert on data interpretation applications and instrumentation experience with personnel management and high performance team excellent written oral communication and presentation expertise effective teamwork with decision influencing and problem solving skills highlymotivated ability to work effectively under pressure to meet deadlines responsibilities this position will report to the director of analytical sciences with responsibilities including but not limited to responsible for method development and sample testingin secondary and tertiary structure characterization cd ftir auc mfi dsc and carbohydrate characterization monosaccharaides sialic acid responsible for method qualification including preparation and review of protocols and reports works closely with upstream and downstream process formulation andqc to ensure the results are communicated rapidly with high quality in collaboration with mass spec group analytical development and bioassay groups develop techniques to isolate product variants and relate molecular structure to function take a lead for troubleshooting of analytical issues provide training to scientists maintain accurate and timely data records and documentation in both eln and paper systems work with cro for outsourcing methods develop and implement innovative valueadded assaysplatforms to help improve similarity characterization write publication of scientific work   location cranbury new jersey  mapview descriptionjob title senior scientistengineer  upstream process developmentjob description   qualifications and experience ms or phd in biotechnology or life science minimum  years for msphd must have demonstrated ability to design and evaluate experiments excellent scientific understanding of biology and engineering principles for mammalian cell culture including cell biology and metabolism medium optimization process development and scaleup flexible in executing and responding to changes in scheduling along with innovating solutions in a transparent team environment must have strong focus on creativity and continuous improvement position responsibilities this position will directly report to the head of upstream development with responsibilities including but not limited to process development  plan and execute experiments performed to evaluate cell lines culture media feeding strategies and process conditions responsible for robust and optimized cell culture manufacturing processes that are developed for every mammalian cell line that has the potential to go into cgmp manufacturing communicate effectively and follow detailed written and verbal instruction ability to clearly communicate with others groups and clients as necessary motivated scientist to develop efficient and robust cell culture processes with high titer and product quality in support of the expanding biosimilar pipeline they will work in a highly inter disciplinary environment and provide technical oversight to junior colleagues excellent scientific understanding of systems biology eg omics approaches and metabolic flux analysis and engineering principles for mammalian cell culture including cell biology and metabolism medium optimization process development and scaleup desire for mechanistic understanding of industrial bioprocess a passion for scientific excellence strong communication and collaboration skills and capability to deliver complex objectives under aggressive timelines should apply for this position optimizing processes already in place to improve product yield knowledge of mammalian cell culture media development and primary recovery which they will be able to independently and proactively apply to the design and execution of process development experimentation methods development and process improvement work in collaboration with operations group to execute protocols experimental plans critical production batches and tech transfers use designed experiments doe to predictunderstandcontrol the impact of process parameters on product quality cqas and production media development and optimization based on cellular demand productivity and critical quality attributes represent functional area in team meetings as required author experimental plans reports and operating procedures maintain a current laboratory notebook with scientific rigor to meet project needs for process development work closely with the cell line development team to guide efforts toward scalable and robust culture processes develop effective mammalian scaledown capabilities and implement effective and scalable process control strategies follow standard operating procedures for laboratory duties experiment design data analysis and process monitoring this position requires a desire and ability to work as an integral part of a multidisciplinary team as well as the demonstration of a high degree of flexibility creativity and initiative applied to the various duties and aspects of the position equipment and facilities  participate in design and procurement of process equipment partner with vendors to deliver state of the art technologies innovate technologies that enable the miniaturization of development systems and increase the efficiency of process development develop efficient and innovative solutions to enable cgmp facility design and operation follow full gmp guidance and fulfill all quality assurance requirements where required operate safely and according to company environmental requirements culture  evaluate technologies and propose ideas for innovation support business development activities as required present data or ideas in team meetings follow all company best practices to minimize cost and meet budgetary requirements head of upstream development may assign other responsibilities as required provide mentoring coaching training to others demonstrated technical leadership skills good oral and written communication skills must be able to work productively in an interdisciplinary team environment   location cranbury new jersey  mapview descriptionjob title senior engineer i ii  equipment qualification manufacturing support job description   opportunity  summary of position the senior engineer i ii equipment qualification manufacturing support position provides a strong leadership as oncobiologics continues its rapid growth  the senior engineer i ii equipment qualification manufacturing support will be responsible for introducing new equipmentsystems and maintenance of validated system into the biologics manufacturing center  qualifications  experience  bs or ms in chemical engineering life sciences or equivalent  minimum of  years of progressive industry experience with facility and equipment qualification in a startup environment the applicant should have an in depth knowledge of equipment qualification especially as it relates to singleuse technology including  cfr part  compliance andor cleaning validation understanding of process validation requirements experience with development or manufacturing as it relates to biologics biosimilars or comparability is a plus thorough understanding of basic statistical tools for data analysis excellent communication skills both verbal and written and the ability to interface effectively with analytical process and business development manufacturing sales and marketing and administration due to international nature of the tasks fluency in written and spoken english  good conceptual analytical problem solving and organizational skills – must be detailoriented well organized and able to work independently and in teams a “handson” energetic individual who enjoys challenges a quick pace and is capable and dedicated to getting the job done   position responsibilities the senior engineer i ii manufacturing support will report to the senior manager group leader manufacturing support with responsibilities including but not limited to creation of rfp’s and urs’ for customized automation and integration of packaged systems such as single use bioreactors chromatography systems tff systems depth filtration systems evaluation of electronic systems to replace paper based systems for manufacturing operation including a process historian data acquisition system in the context of  cfr part  compliance execution of site vmp to ensure a constant state of compliance in a multiproduct multiphase manufacturing facility  act as a main point of contact to validation contractors and manage equipment qualification program author review andor approve documentation in support of oncobiologics equipment qualification program troubleshooting investigation of equipment related nonconformances and deviations ensure seamless and rapid technology transfers from process development through the review of technology transfer protocols and participation on project development teams in order to assess the facility fit of a process   location cranbury new jersey  mapview descriptionjob title scientist iiiiv biophysical characterization analytical sciencesjob description   qualifications  experience   bs ms or phd in analytical chemistry pharmaceutical sciences biochemistry biology or equivalent field a minimum  years of experience with ms or  years with bs is required excellent scientific understanding of assay development and validation for antibodyprotein characterization hands on experience on various liquid chromatographymass spectrometry and liquid chromatography methods eg peptide mapping for sequencing posttranslational modification nlinked and olinked glycosylation characterization good conceptual analytical problem solving and organizational skills – must be detailoriented well organized and able to work independently and be flexible with changing project timeline  familiarity with pepfinder protein discoverer deconvolution pinpoint mascot gpmaw excellent written oral communication and presentation expertise effective teamwork with decision influencing and problem solving skills highlymotivated highlymotivated ability to work effectively under pressure to meet deadlines   job responsibilities   perform method development in glycan structure characterization primary structure characterization amino acid sequence sequence variants intact mass ides subunits disulfide bond conformation amino acid analysis free thiol content posttranslational modification oxidation deamidation glycation terminal variants etc peptide mapping identity oxidationuplc independently perform sample testing data processing data report and data interpretation for biosimilar development and stability studies cqa assessment similarity assessment and forced degradation implement mass spec software tools as needed prepare and review protocols sop and reports maintain accurate and timely data records and documentation in eln and logbooks troubleshooting and solving instrument problems provide training to junior scientists write publication of scientific work operate safely and according to company environmental requirements view descriptionjob title group leader downstream operations job description   opportunity and summary of position the downstream operations group leader will execute and oversee all downstream operations as oncobiologics continues its rapid growth  the downstream operations group leader will be required to ensure cgmp compliant operations occur within the biologics manufacturing center   position responsibilities downstream operations group leader will report to the director of manufacturing with responsibilities including but not limited to lead a team of up to  ftes  direct and  indirect responsible for the manufacture of clarified harvest to support oncobiologics clinical and commercial needs downstream manufacturing oversight from capture chromatography through final ufdf and bulk aliquoting scheduling of all downstream manufacturing activities and personnel this position will work diligently to meet scheduled timelines and will work overtime as required to meet production schedule  weekend holiday and shift work may be required based on manufacturing schedule as determined by area management management of manufacturing operations in accordance with policies and procedures approval of cgmp documentation as it relates to downstream manufacturing inclusive of sops batch records deviations change controls equipment qualification protocols technology transfer protocols and process validation protocols works with quality assurance management to approve executed documentation in support of drug substance release coordination with cross functional areas to ensure that the manufacturing schedule is met serves as key stakeholder in meeting when necessary follow all company best practices to minimize cost and meet budgetary requirements serves as mentor to supervisors and operators by fostering the principles of oncobiologics’ core values works with manufacturing director and quality assurance to establish and execute pai readiness plan management team will assign other responsibilities as required   qualifications and experience msbs degree in life sciences or engineering discipline or equivalent industry experience minimum of  years progressive industry experience of biologics drug substance manufacturing environment  preference will be given to candidates with commercial manufacturing experience minimum of  years of supervisory experience in a biologics drug substance manufacturing operation expert ability in cgmp bioprocess operations particularly downstream processes of mammalian expressed glycoproteins or mabs chromatography  tangential flow filtration strong working knowledge of cgmp manufacturing operations and ability to maintain regulatory requirements for compliance at all times experience with pai readiness is required must be able to provide handson leadership coaching and coordination of needed actions with a focus on achieving production goals must have excellent written verbal and presentation skills with a demonstrated ability to work effectively in a fastpaced team environment must be able to communicate clearly effectively and concisely with subordinates peers and management due to international nature of the tasks fluency in written and spoken english good conceptual analytical problem solving and organizational skills – must be detailoriented well organized and able to work independently and in teams a “handson” energetic individual who enjoys challenges a quick pace and is capable and dedicated to getting the job done   physical requirements meets physical requirements of the job as follows  must have the ability to lift a minimum of  pounds the ability to bend reach stretch climb ladders and work in tight spaces in order to complete job tasks must have the ability to stand for long periods of time may work in a production environment with exposure to latex and bleach  potential exposure to equipment movement hazards noise dangerous materials freezer burns allergens and strong odors  following proper safety procedures minimizes potential for exposure must be able to wear appropriate clean room attire and have the ability to wear surgical masks and all personal protective equipment ppe   location cranbury nj  mapview descriptionjob title associate director quality assurance product releasejob description   qualifications  experience bsms or phd in sciences or engineering will be considered  ideal candidate would possess a comprehensive background in sciences  minimum  years of experience in biopharmaceutical industry with at least  years in qa  prior experience in providing qa support in a commercial setting is required prior experience with biological products is also required product release experience in a commercial setting is a plus experience working in a clinical manufacturing setting and implementing phase appropriate quality systems is an added plus   proven track record participating in health inspections by global authorities is required  must have exceptional communication skills both verbal and written as well as excellent interpersonal skills  must be detail oriented well organized and able to work independently as well as on teams    job description the associate director of quality assurance at oncobiologics’ reports to the director of quality assurance with responsibilities including but not limited to   quality assurance responsible for the review and disposition of finished drug product to be used in clinical trials and ultimately for release of marketed products conduct audits and provide oversight of oncobiologics drug product contractors raw material suppliers and contract laboratories participate in the development of all quality systems required for commercial biologics manufacturing and release responsible for recruitment and leadership of highly talented staff review and approve all procedural documents from manufacturing and analytical testing provide quality review of facility design and enable validation of both production equipment mainly singleuse technology and analytical instrumentation ensure that the organization is compliant with relevant cgmps lead internal audit teams and ensure readiness for global health authority inspections   quality assurance other implement risk management tools and techniques along with development and manufacturing participate in oncobiologics quality council which meets to discuss and resolve issues related to compliance certain responsibilities of the qa director will be delegated to other qa staff as the department grows   culture support business development activities as required support solutions for innovation and collaboration develop customer relationships with peers qa director may assign other responsibilities as required view descriptionjob title senior scientist iii mass spec labjob description   qualification  skills phd ms in analytical chemistry pharmaceutical sciences biochemistry biology or equivalent field minimum    years of pharmaceutical industry experience with antibodyprotein characterization using various liquid chromatographymass spectrometry and liquid chromatography methods eg peptide mapping for sequencing posttranslational modification nlinked and olinked glycosylation characterization experience with biosimilar development is a plus indepth understanding of analytical method development qualification validation good conceptual analytical problem solving and organizational skills – must be detailoriented well organized and able to work independently and be flexible with changing project timeline internal expert on data interpretation applications and instrumentation experience with personnel management and high performance team excellent written oral communication and presentation expertise effective teamwork with decision influencing and problem solving skills highlymotivated highlymotivated ability to work effectively under pressure to meet deadlines   job responsibilities this position will directly report to the director of biophysical characterization analytical sciences with responsibilities including but not limited to perform method development in glycosylation characterization primary structure characterization amino acid sequence sequence variants intact mass ides subunits disulfide bond conformation amino acid analysis extinction coefficient free thiol content posttranslational modification oxidation deamidation glycation terminal variants etc peptide mapping identityuplc oxidationuplc host cell protein using lcms    lead the activities of method qualification and validation including preparation and review of protocols sop and reports lead the sample analysis for biosimilar development and stability studies cqa assessment similarity assessment and forced degradation works closely with upstream and downstream process formulation and qc to ensure the results are communicated rapidly with high quality in collaboration with analytical development and bioassay groups develop techniques to isolate product variants and relate molecular structure to function take a lead for troubleshooting of analytical issues provide training to scientists maintain accurate and timely data records and documentation in both eln and paper systems write publication of scientific work   location cranbury nj  mapview descriptionjob title senior scientist iii biophysical characterizationjob description   qualifications  experience a phd in biophysics biochemistry or equivalent field with    years of industrial experience a ms in biophysics biochemistry or equivalent field minimum  years of experience indepth understanding of biophysical characterization of proteins strong understanding of biophysical method development and qualification handson laboratory experience designing experiments with cd ftir mfi auc and dsc analysis for high order structure characterization and aggregation experience characterizing the structural variants of monoclonal antibodies is preferred good conceptual analytical problem solving and organizational skills – must be detailoriented well organized and able to work independently and be flexible with changing project timeline internal expert on data interpretation applications and instrumentation experience with personnel management and high performance team excellent written oral communication and presentation expertise effective teamwork with decision influencing and problem solving skills highlymotivated ability to work effectively under pressure to meet deadlines   job responsibilities this position will report to the director of biophysical characterization analytical sciences with responsibilities including but not limited to perform method development and sample testing in higher order structure characterization cd ftir auc mfi dsc and protein folding free thiol content disulfide bond linkage responsible for method qualification including preparation and review of sops protocols and reports collaborative interactions with formulation qc cmb upstream and downstream work with cro for outsourcing methods develop and implement innovative valueadded assaysplatforms to support similarity assessment works closely with and to ensure the results are communicated rapidly with high quality in collaboration with analytical development and bioassay groups develop techniques to isolate product variants and relate molecular structure to function take a lead for troubleshooting of analytical issues train coach or mentor scientists maintain accurate and timely data records and documentation in both eln and paper systems write publication of scientific work   location cranbury nj  mapview descriptionjob title scientist iv senior scientist l  bioassay  openings availablejob description   qualifications and experience  phd ms or bs in biology cell biology biochemistry or related field  phd with  –  years ms with  to  years and bs with  to  years of experience in developing cell based bioassays and binding assays  firm knowledge of the biological principles behind mechanisms of drug action cellular pathways and structure – function relationships knowledge of assay development principles and regulatory guidance for assay development validation and data analysis experience in developing spr based assays using the biacore platform is highly desired knowledge of statistical analysis is highly desired proven track record of providing scientifically sound results while multitasking in a fast paced environment effective communication skills ability work in a team oriented environment experience in both research based and gmp environments   responsibilities develop and perform bioassays develop phase appropriate functional assays in multiple formats including cell based assays elisa and spr binding assays based on the knowledge of mechanisms of drug action and assay development principles possess gain a thorough understanding of regulatory guidelines of assay development and analysis provide bioassay support for release stability process development formulation development and investigational studies maintain timely detailed and accurate records of lab activities in eln and logbooks as needed troubleshoot and maintain the equipment utilized within the department support publication and patenting of scientific work keep abreast with established and stateofart science technology and scientific literature collaborate with internal and external resources to develop innovative and novel assay platforms participate in collaborative crossdepartmental projects   location cranbury nj  mapview descriptionjob title senior scientist i  biochemical characterizationjob description   oncobiologics is a rapidly growing biopharmaceutical company focusing on development manufacturing and commercialization of biosimilars located in central new jersey oncobiologics has an immediate opening for a scientist ivsenior scientist i  biochemical characterization qualifications  experience phdms in chemistrybiochemistry or related field minimum  years of experience with phd or  years of experience with ms in the analytical or qc laboratories in pharmaceutical or biopharmaceutical companies must have clear understanding of method development and method validation requirements under regulatory guidelines must have demonstrated the ability to work independently with little supervision and be flexible with changing project timeline to support the process development and the manufacturing experience in glycan analysis and familiarity with cmc and gmp are required demonstrated solid understanding of the principles and practices of broad analytical technologies applicable to the analysis of biologics are desirable   experience in the analysis of monoclonal antibody and the clear understanding of basic statistical analysis are desirable excellent communication skills are required job responsibilities this position will directly report to associate director  analytical development with responsibilities including but not limited to perform method development method validation and routine testing as needed to support crossfunctional teams develop and validate the method for glycan analysis for monoclonal antibodies analyze inprocess control samples drug substances and drug products using technologies such as uvvis cesds icief sec cex hilic rphplc and affinity proteina chromatography operate the instruments and interpret analytical data using empower chemstation astra  karat  sds etc and present results to process development group lead junior scientists in analytical development to provide expertise in instrument maintenance and troubleshooting as well as resolution of oos and oot results keep realtime experiment records in eln and prepare sops protocols technical reports to support the process development and regulatory filling assist associate director with purchasing of new equipment as needed contribute to departmental activities such as safety inspections and internal audits maintains tidiness in laboratory areas while following the safety guidelines provided by ehs culture foster an interactive and crossfunctional team work environment culture follow best practices to reduce cost and meet budgetary requirements while maintaining quality support business development and strategies   location cranbury new jersey  mapview descriptionjob title scientist iiiii bioassay  openings availablejob description   qualifications and experience bs ms in biology cell biology biochemistry biotechnology or related field  –  years of experience with ms and  –  years of experience with bs in performing functional assays including cell based assays and binding assays hands on experience with cell culture aseptic techniques microscopy and basic lab skills sound knowledge of cell biology and biochemistry conceptual understanding of the biological principles behind mechanisms of drug action familiarity with usp guidance for assay development validation and data analysis is highly desired familiarity with spr technology on biacore is a plus experience with cgmp regulations is a plus motivation to be part of a high performance efficient scientific team excellent spoken and written communication skills job responsibilities assist in the development and lifecycle management of bioassays develop functional assays including cell based assays elisas and other binding assays with minimum supervision independently maintain cell cultures prepare reagents and perform various bioassays possess quickly gain an understanding of regulatory guidelines of assay design and data analysis author sops and protocols with minimum supervision perform sample testing and provide results in a timely manner follow cgmp practices as necessary maintain accurate and detailed records of all lab activities maintain bioassay lab and equipment     location cranbury nj  mapview descriptionjob title logistics managerjob description   opportunity and summary of position the manager logistics will execute and oversee logistics operations as oncobiologics continues its rapid growth this position will be required to ensure cgmp compliant operations within the supporting areas of the biologics manufacturing center bmc   position responsibilities  lead a team of up to  ftes responsible for the performance of logistics operations in support of biologics drug substance manufacturing to include revise and maintain standard operating procedures in support of cgmp warehouse operations scheduling of all downstream manufacturing activities and personnel formalize and manage shipment of materials domestically and internationally such as cell banks and bulk drug substance at controlled temperatures establish procedures for the import and export activities for international movement of materials and equipment in conjunction with customs  trade compliance formalize and manage the receipt of cgmp and noncgmp material such as raw materials supplies and equipment establish and maintain inventory control management that will monitor and maintain cgmp and non cgmp materials perform cycle counts perform inventory reconciliation during inventory discrepancy and staging of raw materials consumables and supplies execute the weigh and dispense functions in support of manufacturing operations  the qualified individual will need to interface with manufacturing quality assurance quality control and purchasing support operational preparations through weigh and dispense and material fulfillment perform deviation investigation maintain cgmp documentation establish procedural and operational controls initiate review approve and facilitate change controls maintain a functional and compliant operations and warehouse area ensure that all equipment calibrations as well as preventive maintenance is scheduled present operational updates and data within group meetings as well as in departmental meetings as needed maintain accurate documentation compliant with cgmp guidelines coach and mentor staff as needed management team may assign other responsibilities as required   qualification  experience babs degree in business or science or equivalent   years of combined experience in shipping  warehouse operations cgmp operations within the biopharmaceutical  biotechnology industry weigh and dispense functionality importexport experience of biologics experience developing cold chain solutions such as shipping configurations for controlled ambient °c °c and °c temperature controlled materials handson experience within cgmp operations and cgmp inventory management controls at various scales understand and apply cgmp principles to both supply chain and cgmp manufacturing experience with writing sop’s and developing gmp documentation experience with cgmp facility startup and subsequent qualification activities   years leadership experience with junior staff clearance to drive company vehicles excellent oral and written communication skills will be required to drive a forklift and company provided truck   physical requirements meets physical requirements of the job as follows  must have the ability to lift a minimum of  pounds the ability to bend reach stretch climb ladders and work in tight spaces in order to complete job tasks must have the ability to stand for long periods of time may work in a production environment with exposure to latex and bleach  potential exposure to equipment movement hazards noise dangerous materials freezer burns allergens and strong odors  following proper safety procedures minimizes potential for exposure must be able to wear appropriate clean room attire and have the ability to wear surgical masks and all personal protective equipment ppe   location cranbury nj  mapview descriptionjob title senior scientistengineer purification process developmentjob description   opportunity and summary of position senior scientist engineer purification process development is a position that will support development of robust purification processes for biosimilar monoclonal antibodies and fusion proteins including chromatography and multiple types of filtration processes eg depth dead end tff and nanofiltration this position will support the oncobiologics pipeline which spans early and late phase process development needs  senior scientist engineer purification process development will be responsible for contributing to the planning execution analysis and reporting of experiments related to the development of manufacturing processes for biosimilars job responsibilities evaluation of chromatography resins and membrane adsorbers eg protein a ion exchange mixed mode hydrophobic interaction to be used in purification processes and process models develop scalable chromatography methods that minimize types of buffers and maximize efficiency of operations in manufacturing have core competency in filtration including methods for cell culturefermentation clarification depth filtration tangential flow filtration and viral clearance  this should include working knowledge of filter capacity screening and evaluation implement state of the art science and technology for screening chromatography resins and other separation techniques including automated liquid handling systems maintain a current electronic laboratory notebook with scientific rigor to meet project needs for process development provide input to associated inprocess analytical strategies through the application of design of experiment for rapid speed to first in human studies execute process development enabling analytics required to make development decisions rapidly  should have experience with hplcuplc electrophoretic elisa and associated equipment provide process support to functional areas as needed represent purification development in team meetings as required remain current with respect to chromatography techniques and equipment work to deliver state of the art technologies that innovate and are a differentiator for oncobiologics must be familiar with gmp guidances and support manufacturing with appropriately developed process including documentation of process knowledge operate safely and according to company environmental requirements author and review documentation including but not limited to technical transfer protocols and development reports ensure seamless and rapid technology transfers to clinical manufacturing inhouse or outsourced partner through technology transfer protocols and participation on project development teams maintain current lab environment eg buffersolution preparation raw material ordering equipment maintenance and repair hazardous waste disposal qualifications  experience the company is seeking an individual with the following qualifications and who is willing to make a longterm commitment to the organization bs ms phd biochemistry chemistry chemical engineering or equivalent field  minimum  years of experience in absence of graduate degree  years if ms or  years with phd have a working knowledge of purification instruments and their associated software specifically ge healthcare akta instruments and unicorn software is a plus demonstrated ability in all modes of chromatography including column packing and buffersolution preparation demonstrated ability in filtration principles and practice including general operation as well as capacity determination the applicant should have a working knowledge of the progression of “micro” scale purification development through confirmation of process at pilot scale the applicant should have a working knowledge of virus inactivation and small virus retention filtration  experience in viral clearance studies is a plus excellent communication skills both verbal and written and the ability to interface effectively with analytical process and business development is required due to international nature of the tasks fluency in written and spoken english good conceptual analytical problem solving and organizational skills – must be detailoriented well organized and able to work independently and in teams a “handson” energetic individual who enjoys challenges a quick pace and is capable and dedicated to getting the job done an assertive takecharge scientist or engineer with a strong results orientation positive “can do” attitude and a sense of urgency to get things done however with the ability to listen to learn about and build upon organizational best practices and successes a competent fast learning individual with the ability to multitask and adapt to change a mature thinking and acting scientist or engineer with good common sense and judgment   location cranbury nj  mapview descriptionjob title senior engineer i ii  upstream process engineer manufacturing supportjob description   the senior engineer i ii upstream manufacturing support is a new position created to provide strong leadership as oncobiologics continues its rapid growth  the senior engineer i ii manufacturing support will be responsible for the introduction of all biosimilar candidates from process development to the biologics manufacturing center qualifications and experience bs or ms in chemical engineering life sciences or equivalent minimum of  years progressive industry experience with biologics drug substance scaleup and manufacturing demonstrated ability in clinical cgmp bioprocess operations particularly upstream processes of mammalian expressed glycoproteins or mabs the applicant should have an indepth knowledge in the principles of process scaling upstream processes from process development to clinical manufacturing cell culture unit operations as well as associated singleuse technology the applicant should have a working knowledge of equipment qualification and process validation including  cfr part  compliance experience with development or manufacturing as it relates to biologics biosimilars or comparability is a plus thorough understanding of basic statistical tools for process data analysis  excellent communication skills both verbal and written and the ability to interface effectively with analytical process and business development manufacturing sales and marketing and administration due to international nature of the tasks fluency in written and spoken english good conceptual analytical problem solving and organizational skills – must be detailoriented well organized and able to work independently and in teams a “handson” energetic individual who enjoys challenges a quick pace and is capable and dedicated to getting the job done job responsibilities ensure seamless and rapid technology transfers from upstream process development through the review of upstream technology transfer protocols and participation on project development teams author review andor approve documentation for upstream manufacturing processes including but not limited to master batch records standard operating procedures production bill of materials process flow diagrams and campaign summary reports troubleshooting investigation of upstream process nonconformances and deviations management of the oncobiologics’ material specification process  this includes review and approval of material specifications for completeness and accuracy  provide technical advice on raw material monographs to ensure compliance with applicable region’s compendia compilation of upstream process data from clinical batches to establish critical processing parameters and par review of rfp’s and urs’ for customized automation and integration of packaged systems such as single use bioreactors chromatography systems tff systems depth filtration systems execution of site vmp to ensure a constant state of compliance in a multiproduct multiphase manufacturing facility   location cranbury nj  mapview descriptionjob title engineer iii manufacturing supportjob description opportunity and summary of position the engineer iii manufacturing support is a new position created to provide strong leadership as oncobiologics continues its rapid growth  the engineer iii manufacturing support will be responsible for the introduction of all biosimilar candidates from process development to the biologics manufacturing center position responsibilities the engineer iii manufacturing support will report to the senior manager group leader manufacturing support with responsibilities including but not limited to ensure seamless and rapid technology transfers from upstream and downstream process development through the review of technology transfer protocols and participation on project development teams author review andor approve documentation for manufacturing processes including but not limited to master batch records standard operating procedures production bill of materials process flow diagrams and campaign summary reports troubleshooting investigation of process nonconformances and deviations management of the oncobiologics’ material specification process  this includes review and approval of material specifications for completeness and accuracy  provide technical advice on raw material monographs to ensure compliance with applicable region’s compendia compilation of process data from clinical batches to establish critical processing parameters and par reviewauthor of rfp’s and urs’ for customized automation and integration of packaged systems such as single use bioreactors chromatography systems tff systems depth filtration systems assist in execution of site vmp to ensure a constant state of compliance in a multiproduct multiphase manufacturing facility qualifications and skills bs or ms in chemical engineering life sciences or equivalent minimum of    years of industry experience with biologics drug substance scaleup and manufacturing demonstrated ability in clinical cgmp bioprocess operations of mammalian expressed glycoproteins or mabs the applicant should have an indepth knowledge in the principles of process scaling processes from process development to clinical manufacturing cell culture and purification unit operations as well as associated singleuse technology experience with development or manufacturing as it relates to biologics biosimilars or comparability is a plus thorough understanding of basic statistical tools for process data analysis excellent communication skills both verbal and written and the ability to interface effectively with analytical process and business development manufacturing sales and marketing and administration due to international nature of the tasks fluency in written and spoken english good conceptual analytical problem solving and organizational skills – must be detailoriented well organized and able to work independently and in teams a “handson” energetic individual who enjoys challenges a quick pace and is capable and dedicated to getting the job done view descriptionjob title supervisor upstream operationsjob description   opportunity and summary of position the supervisor upstream operations will execute and supervise upstream manufacturing operations as oncobiologics continues its rapid growth  the supervisor upstream operations will be required to execute and supervise cgmp operations within the biologics manufacturing center  this is a nonexempt position position responsibilities upstream supervisor upstream operations will report to the group leader upstream operations with responsibilities including but not limited to this position will work diligently to meet scheduled timelines and will work overtime as required to meet production schedule  weekend holiday and shift work will be required based on manufacturing schedule as determined by area management performance and oversight of upstream cgmp operations in accordance with standard operating procedures sop’s master batch records mbr’s equipment qualification protocols and other applicable instructional documentation communicates status of operations troubleshoots process issues and remedies safety  maintenance issues with area management provides review of executed documentation for completeness and accuracy and works with quality assurance to reconcile comments participate in starting up facility and process equipment reviews revises and authors sops deviations and change controls as directed by area management innovate technologies that embrace qrm continuous improvement reduce manufacturing costs and increase manufacturing efficiency ensures that all production equipment is functioning properly and production processes meet documented quality standards follow all company best practices to minimize cost and meet budgetary requirements management team may assign other responsibilities as required mentor a staff of up to six  direct reports qualifications and skills bs life sciences or equivalent   years progressive industry experience within an upstream biologics drug substance manufacturing environment superior ability in cgmp bioprocess operations particularly upstream processes of mammalian expressed glycoproteins or mabs aseptic technique cell culture bioreactor operations excellent communication skills both verbal and written and the ability to interface effectively with analytical process and business development manufacturing sales and marketing and administration due to international nature of the tasks fluency in written and spoken english good conceptual analytical problem solving and organizational skills – must be detailoriented well organized and able to work independently and in teams a “handson” energetic individual who enjoys challenges a quick pace and is capable and dedicated to getting the job done physical requirements meets physical requirements of the job as follows  must have the ability to lift a minimum of  pounds the ability to bend reach stretch climb ladders and work in tight spaces in order to complete job tasks must have the ability to stand for long periods of time works in production environment with exposure to latex and bleach  potential exposure to equipment movement hazards noise dangerous materials freezer burns allergens and strong odors  following proper safety procedures minimizes potential for exposure must be able to wear appropriate clean room attire and have the ability to wear surgical masks and all personal protective equipment ppe view descriptionjob title supervisor downstream operationsjob description   opportunity and summary of position the supervisor downstream operations will execute and supervise downstream manufacturing operations as oncobiologics continues its rapid growth  the supervisor downstream operations will be required to execute and supervise cgmp operations within the biologics manufacturing center  this is an exempt position   position responsibilities supervisor downstream operations will report to the group leader downstream operations with responsibilities including but not limited to this position will work diligently to meet scheduled timelines and will work as required to meet production schedule  weekend holiday and shift work will be required based on manufacturing schedule as determined by area management performance and oversight of downstream cgmp operations in accordance with standard operating procedures sop’s master batch records mbr’s equipment qualification protocols and other applicable instructional documentation communicates status of operations troubleshoots process issues and remedies safety  maintenance issues with area management provides review of executed documentation for completeness and accuracy and works with quality assurance to reconcile comments participate in starting up facility and process equipment reviews revises and authors sops deviations and change controls as directed by area management innovate technologies that embrace qrm continuous improvement reduce manufacturing costs and increase manufacturing efficiency ensures that all production equipment is functioning properly and production processes meet documented quality standards follow all company best practices to minimize cost and meet budgetary requirements management team may assign other responsibilities as required mentor a staff of up to six  direct reports qualifications and skills bs life sciences or equivalent   years progressive industry experience within a downstream biologics drug substance manufacturing environment superior ability in cgmp bioprocess operations particularly downstream processes of mammalian expressed glycoproteins or mabs chromatography  tangential flow filtration excellent communication skills both verbal and written and the ability to interface effectively with analytical process and business development manufacturing sales and marketing and administration due to international nature of the tasks fluency in written and spoken english good conceptual analytical problem solving and organizational skills – must be detailoriented well organized and able to work independently and in teams a “handson” energetic individual who enjoys challenges a quick pace and is capable and dedicated to getting the job done   physical requirements meets physical requirements of the job as follows  must have the ability to lift a minimum of  pounds the ability to bend reach stretch climb ladders and work in tight spaces in order to complete job tasks must have the ability to stand for long periods of time works in production environment with exposure to latex and bleach  potential exposure to equipment movement hazards noise dangerous materials freezer burns allergens and strong odors  following proper safety procedures minimizes potential for exposure must be able to wear appropriate clean room attire and have the ability to wear surgical masks and all personal protective equipment ppe view descriptionjob title operator iii downstream operationsjob description opportunity and summary of position the operator iii downstream operations will execute downstream manufacturing operations as oncobiologics continues its rapid growth  the operator iii downstream operations will be required to execute cgmp operations within the biologics manufacturing center  this is a nonexempt position position responsibilities operator iii downstream operations will report to supervisor downstream operations with responsibilities including but not limited to this position will work diligently to meet scheduled timelines and will work overtime as required to meet production schedule  weekend holiday and shift work will be required based on manufacturing schedule as determined by area management performance of downstream cgmp operations in accordance with standard operating procedures sops master batch records mbrs equipment qualification protocols and other applicable instructional documentation communicates status of operations process issues and safety  maintenance issues to area management immediately participate in starting up facility and process equipment reviews revises and authors sops as directed by area management follow all company best practices to minimize cost and meet budgetary requirements management team may assign other responsibilities as required qualifications and skills bs life sciences or equivalent     years industry experience within a downstream biologics drug substance manufacturing environment limited ability in cgmp bioprocess operations particularly downstream processes of mammalian expressed glycoproteins or mabs preferred chromatography  tangential flow filtration excellent communication skills both verbal and written and the ability to interface effectively with analytical process and business development manufacturing sales and marketing and administration due to international nature of the tasks fluency in written and spoken english good conceptual analytical problem solving and organizational skills – must be detailoriented well organized and able to work independently and in teams a “handson” energetic individual who enjoys challenges a quick pace and is capable and dedicated to getting the job done   physical requirements   meets physical requirements of the job as follows  must have the ability to lift a minimum of  pounds the ability to bend reach stretch climb ladders and work in tight spaces in order to complete job tasks must have the ability to stand for long periods of time works in production environment with exposure to latex and bleach  potential exposure to equipment movement hazards noise dangerous materials freezer burns allergens and strong odors  following proper safety procedures minimizes potential for exposure must be able to wear appropriate clean room attire and have the ability to wear surgical masks and all personal protective equipment ppe view descriptionjob title senior operator iii downstream operations job description opportunity and summary of position the sr operator iii downstream operations will execute downstream manufacturing operations as oncobiologics continues its rapid growth  the sr operator iii downstream operations will be required to execute cgmp operations within the biologics manufacturing center  this is a nonexempt position position responsibilities sr operator iii downstream operations will report to supervisor downstream operations with responsibilities including but not limited to this position will work diligently to meet scheduled timelines and will work overtime as required to meet production schedule  weekend holiday and shift work will be required based on manufacturing schedule as determined by area management performance of downstream cgmp operations in accordance with standard operating procedures sops master batch records mbrs equipment qualification protocols and other applicable instructional documentation communicates status of operations process issues and safety  maintenance issues to area management immediately and provides potential solutions provides initial review of executed documentation for completeness and accuracy participate in starting up facility and process equipment reviews revises and authors sops and deviations as directed by area management innovate technologies that embrace continuous improvement reduce manufacturing costs and increase manufacturing efficiency ensures that all production equipment is functioning properly and production processes meet documented quality standards follow all company best practices to minimize cost and meet budgetary requirements management team may assign other responsibilities as required qualifications and skills bs life sciences or equivalent    years progressive industry experience within a downstream biologics drug substance manufacturing environment demonstrated ability in cgmp bioprocess operations particularly downstream processes of mammalian expressed glycoproteins or mabs required chromatography  tangential flow filtration excellent communication skills both verbal and written and the ability to interface effectively with analytical process and business development manufacturing sales and marketing and administration due to international nature of the tasks fluency in written and spoken english good conceptual analytical problem solving and organizational skills – must be detailoriented well organized and able to work independently and in teams a “handson” energetic individual who enjoys challenges a quick pace and is capable and dedicated to getting the job done view descriptionjob title senior operator iii upstream operationsjob description   opportunity and summary of position the sr operator iii upstream operations will execute upstream manufacturing operations as oncobiologics continues its rapid growth  the sr operator iii upstream operations will be required to execute cgmp operations within the biologics manufacturing center  this is a nonexempt position position responsibilities sr operator iii upstream operations will report to supervisor upstream operations with responsibilities including but not limited to this position will work diligently to meet scheduled timelines and will work overtime as required to meet production schedule  weekend holiday and shift work will be required based on manufacturing schedule as determined by area management performance of upstream cgmp operations in accordance with standard operating procedures sops master batch records mbrs equipment qualification protocols and other applicable instructional documentation communicates status of operations process issues and safety  maintenance issues to area management immediately and provides potential solutions provides initial review of executed documentation for completeness and accuracyparticipate in starting up facility and process equipment reviews revises and authors sops and deviations as directed by area management innovate technologies that embrace continuous improvement reduce manufacturing costs and increase manufacturing efficiency ensures that all production equipment is functioning properly and production processes meet documented quality standards follow all company best practices to minimize cost and meet budgetary requirements management team may assign other responsibilities as required qualifications and skills bs life sciences or equivalent     years progressive industry experience within an upstream biologics drug substance manufacturing environment demonstrated ability in cgmp bioprocess operations particularly upstream processes of mammalian expressed glycoproteins or mabs required aseptic technique cell culture bioreactor operations excellent communication skills both verbal and written and the ability to interface effectively with analytical process and business development manufacturing sales and marketing and administration due to international nature of the tasks fluency in written and spoken english good conceptual analytical problem solving and organizational skills – must be detailoriented well organized and able to work independently and in teams a “handson” energetic individual who enjoys challenges a quick pace and is capable and dedicated to getting the job done   oncobiologics inc clarke drive cranbury nj  usainfooncobiologicscom about careers oncobiologics  product pipeline oncobiologics home  careers  partner  news  investors  contact about about oncobiologicsboard of directorssenior management biosymphony model biosymphony modelbiosimilars pipeline development platform cmc developmentregulatory  clinical developmentfacility tour manufacturing manufacturing platformgmp manufacturing facility tour publications biosymphony model understanding biosimilars development biosimilars pipeline product pipeline   oncobiologics inc clarke drive cranbury nj  usainfooncobiologicscom about careers oncobiologics inc  product pipeline review   trends statistics segment and forecasts market size share analysis  market research store     gmt office hours  uscan toll free  us office no home categories become publisher news about us contact us select category consumer goods food  beverage heavy industry life sciences marketing  market research public sector service industries technology  media semiconductor chemical and materials metallurgical market research search home  life sciences  pharmaceuticals oncobiologics inc  product pipeline review   published dec  format pdf  global markets direct  number of pages   code mrs   report details table of content inquiry for buying request sample oncobiologics inc  product pipeline review   summary global markets direct’s ‘oncobiologics inc  product pipeline review  ’ provides an overview of the oncobiologics inc’s pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of oncobiologics inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope  the report provides brief overview of oncobiologics inc including business description key information and facts and its locations and subsidiaries  the report reviews current pipeline of oncobiologics inc’s human therapeutic division and enlists all their major and minor projects  the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio  the report summarizes all the dormant and discontinued pipeline projects  latest company statement  latest news and deals relating to the oncobiologics inc’s pipeline products reasons to buy  evaluate oncobiologics inc’s strategic position with total access to detailed information on its product pipeline  assess the growth potential of oncobiologics inc in its therapy areas of focus  identify new drug targets and therapeutic classes in the oncobiologics inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas  exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps  develop strategic initiatives by understanding the focus areas of oncobiologics inc and exploit collaboration and partnership opportunities  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  plan mergers and acquisitions effectively by identifying the most promising pipeline of oncobiologics inc  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope  explore the dormant and discontinued projects of oncobiologics inc and identify potential opportunities in those areas  avoid intellectual property rights related issues table of contents table of contents  list of tables  list of figures  oncobiologics inc snapshot  oncobiologics inc overview  key information  key facts  oncobiologics inc  research and development overview  key therapeutic areas  oncobiologics inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  oncobiologics inc  pipeline products glance  oncobiologics inc  clinical stage pipeline products  phase i productscombination treatment modalities  oncobiologics inc  early stage pipeline products  preclinical productscombination treatment modalities  oncobiologics inc  drug profiles  adalimumab biosimilar  product description  mechanism of action  rd progress  bevacizumab biosimilar  product description  mechanism of action  rd progress  cetuximab biosimilar  product description  mechanism of action  rd progress  denosumab biosimilar  product description  mechanism of action  rd progress  golimumab biosimilar  product description  mechanism of action  rd progress  tocilizumab biosimilar  product description  mechanism of action  rd progress  trastuzumab biosimilar  product description  mechanism of action  rd progress  ustekinumab biosimilar  product description  mechanism of action  rd progress  oncobiologics inc  pipeline analysis  oncobiologics inc  pipeline products by target  oncobiologics inc  pipeline products by route of administration  oncobiologics inc  pipeline products by molecule type  oncobiologics inc  pipeline products by mechanism of action  oncobiologics inc  recent pipeline updates  oncobiologics inc  dormant projects  oncobiologics inc  locations and subsidiaries  head office  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of tables oncobiologics inc key information  oncobiologics inc key facts  oncobiologics inc  pipeline by indication   oncobiologics inc  pipeline by stage of development   oncobiologics inc  monotherapy products in pipeline   oncobiologics inc  phase i   oncobiologics inc  preclinical   oncobiologics inc  pipeline by target   oncobiologics inc  pipeline by route of administration   oncobiologics inc  pipeline by molecule type   oncobiologics inc  pipeline products by mechanism of action   oncobiologics inc  recent pipeline updates   oncobiologics inc  dormant developmental projects  list of figures oncobiologics inc  pipeline by top  indication   oncobiologics inc  pipeline by stage of development   oncobiologics inc  monotherapy products in pipeline   oncobiologics inc  pipeline by top  target   oncobiologics inc  pipeline by top  route of administration   oncobiologics inc  pipeline by top  molecule type   oncobiologics inc  pipeline products by top  mechanism of action   inquiry for buying please fill your details below to inquire about this report  indicates required fields name email phone name of company titledesignation country name select country andorra united arab emirates afghanistan antigua and barbuda anguilla albania armenia angola antarctica argentina american samoa austria australia aruba åland islands azerbaijan bosnia and herzegovina barbados bangladesh belgium burkina faso bulgaria bahrain burundi benin saint barthélemy bermuda brunei darussalam bolivia plurinational state of bonaire sint eustatius and saba brazil bahamas bhutan bouvet island botswana belarus belize canada cocos keeling islands congo the democratic republic of the central african republic congo switzerland côte divoire cook islands chile cameroon china colombia costa rica cuba cape verde curaçao christmas island cyprus czech republic germany djibouti denmark dominica dominican republic algeria ecuador estonia egypt western sahara eritrea spain ethiopia finland fiji falkland islands malvinas micronesia federated states of faroe islands france gabon united kingdom grenada georgia french guiana guernsey ghana gibraltar greenland gambia guinea guadeloupe equatorial guinea greece south georgia and the south sandwich islands guatemala guam guineabissau guyana hong kong heard island and mcdonald islands honduras croatia haiti hungary indonesia ireland israel isle of man india british indian ocean territory iraq iran islamic republic of iceland italy jersey jamaica jordan japan kenya kyrgyzstan cambodia kiribati comoros saint kitts and nevis korea democratic peoples republic of korea republic of kuwait cayman islands kazakhstan lao peoples democratic republic lebanon saint lucia liechtenstein sri lanka liberia lesotho lithuania luxembourg latvia libya morocco monaco moldova republic of montenegro saint martin french part madagascar marshall islands macedonia the former yugoslav republic of mali myanmar mongolia macao northern mariana islands martinique mauritania montserrat malta mauritius maldives malawi mexico malaysia mozambique namibia new caledonia niger norfolk island nigeria nicaragua netherlands norway nepal nauru niue new zealand oman panama peru french polynesia papua new guinea philippines pakistan poland saint pierre and miquelon pitcairn puerto rico palestinian state of portugal palau paraguay qatar réunion romania serbia russian federation rwanda saudi arabia solomon islands seychelles sudan sweden singapore saint helena ascension and tristan da cunha slovenia svalbard and jan mayen slovakia sierra leone san marino senegal somalia suriname south sudan sao tome and principe el salvador sint maarten dutch part syrian arab republic swaziland turks and caicos islands chad french southern territories togo thailand tajikistan tokelau timorleste turkmenistan tunisia tonga turkey trinidad and tobago tuvalu taiwan province of china tanzania united republic of ukraine uganda united states minor outlying islands united states uruguay uzbekistan holy see vatican city state saint vincent and the grenadines venezuela bolivarian republic of virgin islands british virgin islands us viet nam vanuatu wallis and futuna samoa yemen mayotte south africa zambia zimbabwe how can we help you refresh captcha submit request sample please fill your details below to receive sample report  indicates required fields name email phone name of company titledesignation country name select country andorra united arab emirates afghanistan antigua and barbuda anguilla albania armenia angola antarctica argentina american samoa austria australia aruba åland islands azerbaijan bosnia and herzegovina barbados bangladesh belgium burkina faso bulgaria bahrain burundi benin saint barthélemy bermuda brunei darussalam bolivia plurinational state of bonaire sint eustatius and saba brazil bahamas bhutan bouvet island botswana belarus belize canada cocos keeling islands congo the democratic republic of the central african republic congo switzerland côte divoire cook islands chile cameroon china colombia costa rica cuba cape verde curaçao christmas island cyprus czech republic germany djibouti denmark dominica dominican republic algeria ecuador estonia egypt western sahara eritrea spain ethiopia finland fiji falkland islands malvinas micronesia federated states of faroe islands france gabon united kingdom grenada georgia french guiana guernsey ghana gibraltar greenland gambia guinea guadeloupe equatorial guinea greece south georgia and the south sandwich islands guatemala guam guineabissau guyana hong kong heard island and mcdonald islands honduras croatia haiti hungary indonesia ireland israel isle of man india british indian ocean territory iraq iran islamic republic of iceland italy jersey jamaica jordan japan kenya kyrgyzstan cambodia kiribati comoros saint kitts and nevis korea democratic peoples republic of korea republic of kuwait cayman islands kazakhstan lao peoples democratic republic lebanon saint lucia liechtenstein sri lanka liberia lesotho lithuania luxembourg latvia libya morocco monaco moldova republic of montenegro saint martin french part madagascar marshall islands macedonia the former yugoslav republic of mali myanmar mongolia macao northern mariana islands martinique mauritania montserrat malta mauritius maldives malawi mexico malaysia mozambique namibia new caledonia niger norfolk island nigeria nicaragua netherlands norway nepal nauru niue new zealand oman panama peru french polynesia papua new guinea philippines pakistan poland saint pierre and miquelon pitcairn puerto rico palestinian state of portugal palau paraguay qatar réunion romania serbia russian federation rwanda saudi arabia solomon islands seychelles sudan sweden singapore saint helena ascension and tristan da cunha slovenia svalbard and jan mayen slovakia sierra leone san marino senegal somalia suriname south sudan sao tome and principe el salvador sint maarten dutch part syrian arab republic swaziland turks and caicos islands chad french southern territories togo thailand tajikistan tokelau timorleste turkmenistan tunisia tonga turkey trinidad and tobago tuvalu taiwan province of china tanzania united republic of ukraine uganda united states minor outlying islands united states uruguay uzbekistan holy see vatican city state saint vincent and the grenadines venezuela bolivarian republic of virgin islands british virgin islands us viet nam vanuatu wallis and futuna samoa yemen mayotte south africa zambia zimbabwe how can we help you refresh captcha submit related reports opioidinduced constipation oic  pipeline review h  jul  global markets direct  pages    code  mrs   opioidinduced constipation oic  pipeline review h  summary global markets directs latest pharmaceutical and healthcare disease pipeline guide opioidinduced constipation oic  pipeline review h  provides an overview of the opioidinduced constipation oic toxicology pipeline landscape opioids are effective pain relievers but often have the side effect of constipation these medicines affect the gastrointestinal tract in a variety of ways opioids increase the amo read more chemotherapy induced neutropenia  pipeline review h  jul  global markets direct  pages    code  mrs   chemotherapy induced neutropenia  pipeline review h  summary global markets directs latest pharmaceutical and healthcare disease pipeline guide chemotherapy induced neutropenia  pipeline review h  provides an overview of the chemotherapy induced neutropenia toxicology pipeline landscape chemotherapyinduced neutropenia is a very common side effect of cancer treatment symptoms include severe fatigue weakness anxiety lack of energy shortness of breath headaches pa read more chemotherapy induced nausea and vomiting  pipeline review h  jul  global markets direct  pages    code  mrs   chemotherapy induced nausea and vomiting  pipeline review h  summary global markets directs latest pharmaceutical and healthcare disease pipeline guide chemotherapy induced nausea and vomiting  pipeline review h  provides an overview of the chemotherapy induced nausea and vomiting toxicology pipeline landscape chemotherapy induced nausea and vomiting or cinv is nausea and vomiting that results specifically from treatment with chemotherapy drugs symptoms include a rapi read more px purinoceptor  pz receptor or prx  pipeline review h  jul  global markets direct  pages    code  mrs   px purinoceptor  pz receptor or prx  pipeline review h  summary according to the recently published report px purinoceptor   pipeline review h  px purinoceptor  pz receptor or prx pipeline target constitutes close to  molecules out of which approximately  molecules are developed by companies px purinoceptor  pz receptor or prx  px purinoceptor  is a protein encoded by the prx gene it acts as receptor for atp that acts as a ligandgated i read more smoothened homolog protein gx or smo  pipeline review h  jul  global markets direct  pages    code  mrs   smoothened homolog protein gx or smo  pipeline review h  summary smoothened homolog protein gx or smo  smoothened homolog smo is a g proteincoupled receptor that probably associates with the patched protein ptch to transduce the hedgehogs proteins signal binding of sonic hedgehog shh to its receptor is thought to prevent normal inhibition by patched of smoothened smo it is required for the accumulation of kif and gli in the cilia smoothened homolog protein gx read more metabotropic glutamate receptor  gprcd or mglur or grm  pipeline review h  jul  global markets direct  pages    code  mrs   metabotropic glutamate receptor  gprcd or mglur or grm  pipeline review h  summary metabotropic glutamate receptor  gprcd or mglur or grm pipeline target constitutes close to  molecules out of which approximately  molecules are developed by companies and remaining by the universitiesinstitutes the latest report metabotropic glutamate receptor   pipeline review h  outlays comprehensive information on the metabotropic glutamate receptor  gprcd or mglur o read more g protein coupled bile acid receptor  g protein coupled receptor gpcr or membrane type receptor for bile acids or hbg or gpr or gpbar  pipeline review h  jul  global markets direct  pages    code  mrs   g protein coupled bile acid receptor  g protein coupled receptor gpcr or membrane type receptor for bile acids or hbg or gpr or gpbar  pipeline review h  summary according to the recently published report g protein coupled bile acid receptor   pipeline review h  g protein coupled bile acid receptor  g protein coupled receptor gpcr or membrane type receptor for bile acids or hbg or gpr or gpbar pipeline target constitutes close to  molecules out of read more alpha c adrenergic receptor alpha  adrenergic receptor subtype c or alpha c adrenoreceptor or adrac  pipeline review h  jul  global markets direct  pages    code  mrs   alpha c adrenergic receptor alpha  adrenergic receptor subtype c or alpha c adrenoreceptor or adrac  pipeline review h  summary alpha c adrenergic receptor alpha  adrenergic receptor subtype c or alpha c adrenoreceptor or adrac  alphac adrenergic receptor or adrac is an alpha adrenergic receptor it mediates the catecholamineinduced inhibition of adenylate cyclase through the action of g proteins this receptor plays a critical role in regulating neurotransmitt read more tumor necrosis factor receptor superfamily member  glucocorticoid induced tumor necrosis factor receptor or activation inducible tnfr family receptor or glucocorticoid induced tnfr related protein or cd or tnfrsf  pipeline review h  jul  global markets direct  pages    code  mrs   tumor necrosis factor receptor superfamily member  glucocorticoid induced tumor necrosis factor receptor or activation inducible tnfr family receptor or glucocorticoid induced tnfr related protein or cd or tnfrsf  pipeline review h  summary tumor necrosis factor receptor superfamily member  glucocorticoid induced tumor necrosis factor receptor or activation inducible tnfr family receptor or glucocorticoid induced tnfr related protein or cd or tnfrsf pipeline targe read more ephrin type b receptor  hepatoma transmembrane kinase or tyrosine protein kinase tyro or ephb or ec   pipeline review h  jul  global markets direct  pages    code  mrs   ephrin type b receptor  hepatoma transmembrane kinase or tyrosine protein kinase tyro or ephb or ec   pipeline review h  summary according to the recently published report ephrin type b receptor   pipeline review h  ephrin type b receptor  hepatoma transmembrane kinase or tyrosine protein kinase tyro or ephb or ec  pipeline target constitutes close to  molecules out of which approximately  molecules are developed by companies and remaining read more payment mode single user  usd multi user  usd corporate user  usd latest report  global nonslip epoxy glass flake paint market research report  global parking sensors market research report  global nitrogen oxide sensor market research report  global nuclear density gauge market research report  global automotive interior materials market research report view more latest news global chitosan market set for rapid growth to reach usd  billion by  zion market research has published a new report titled chitosan market for water treatment biomed development of ecommerce to reshape global mobile hotspot router market mobile hotspot is a popular feature on smart phones that provide wireless internet access on many global carotenoids market is expected to reach around usd  billion in  zion market research has published a new report titled carotenoids market by type astaxanthin be soaring demand from food  beverages industry to act as prime driving for ascorbic acid market reports zion market research ascorbic acid is extensively available in nature mostly rich in leafy vegetables and fresh fruits global energy management system ems market is set for a rapid growth and is expected to reach usd  million by  zion market research has published a new report titled energy management system market ems by so view more single user  usd view pricing find help how to order disclaimer faqs return policy sitemap our company about us terms and conditions privacy policy we accept the following payment methods     market research store  market research reports oncobiologics inc  product pipeline review    rnr market research advanced search     salesrnrmarketresearchcom search market research reports ﻿ market research assistance salesrnrmarketresearchcom on the web related markets biotechnologybiomaterialsbiomarkersstem celldrug discoveryindustrial biotechnologywound careenzymemicroarraybiopharmaceuticalcell culture related market reportsoncobiologics inc  product pipeline review   home  life sciences  biotechnology  report detail oncobiologics inc  product pipeline review   publisher name  global markets direct date nov no of pages  price single user license us  corporate user license us  report descriptiontable of contentnews  blogother reportsour offerings global markets directs oncobiologics inc product pipeline review  provides an overview of the oncobiologics incs pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of oncobiologics incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope the report provides brief overview of oncobiologics inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of oncobiologics incs human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement latest news and deals relating to the oncobiologics incs pipeline products reasons to buy evaluate oncobiologics incs strategic position with total access to detailed information on its product pipeline assess the growth potential of oncobiologics inc in its therapy areas of focus identify new drug targets and therapeutic classes in the oncobiologics incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of oncobiologics inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of oncobiologics inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of oncobiologics inc and identify potential opportunities in those areas avoid intellectual property rights related issues oncobiologics inc  product pipeline review   table of contents table of contents  list of tables  list of figures  oncobiologics inc snapshot  oncobiologics inc overview  key information  key facts  oncobiologics inc  research and development overview  key therapeutic areas  oncobiologics inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  oncobiologics inc  pipeline products glance  oncobiologics inc  clinical stage pipeline products  phase i productscombination treatment modalities  oncobiologics inc  early stage pipeline products  preclinical productscombination treatment modalities  oncobiologics inc  drug profiles  adalimumab biosimilar  product description  mechanism of action  rd progress  bevacizumab biosimilar  product description  mechanism of action  rd progress  cetuximab biosimilar  product description  mechanism of action  rd progress  rituximab biosimilar  product description  mechanism of action  rd progress  trastuzumab biosimilar  product description  mechanism of action  rd progress  oncobiologics inc  pipeline analysis  oncobiologics inc  pipeline products by target  oncobiologics inc  pipeline products by route of administration  oncobiologics inc  pipeline products by molecule type  oncobiologics inc  pipeline products by mechanism of action  oncobiologics inc  recent pipeline updates  oncobiologics inc  dormant projects  oncobiologics inc  locations and subsidiaries  head office  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of tables oncobiologics inc key information  oncobiologics inc key facts  oncobiologics inc  pipeline by indication   oncobiologics inc  pipeline by stage of development   oncobiologics inc  monotherapy products in pipeline   oncobiologics inc  phase i   oncobiologics inc  preclinical   oncobiologics inc  pipeline by target   oncobiologics inc  pipeline by route of administration   oncobiologics inc  pipeline by molecule type   oncobiologics inc  pipeline products by mechanism of action   oncobiologics inc  recent pipeline updates   oncobiologics inc  dormant developmental projects  list of figures oncobiologics inc  pipeline by top  indication   oncobiologics inc  pipeline by stage of development   oncobiologics inc  monotherapy products in pipeline   oncobiologics inc  pipeline by top  target   oncobiologics inc  pipeline by top  route of administration   oncobiologics inc  pipeline by top  molecule type   oncobiologics inc  pipeline products by top  mechanism of action   renewable energy sources needs to boost global microgrids marketthe global market for microgrid was worth us billion in  and is anticipated to touch an estimate of us billion by  dealers in the market for microgrids are incessantly improving the network hostinghellipmanufacturing trends in the coming daysthe manufacturing industry may be encountering some breezes but it is irrefutably in the middle of a technological revival that is altering the appearance structures and practices of the modern factory notwithstanding the jeopardies andhelliptop  emerging technologiesthe world economic forum wef and scientific american lately unveiled the major technological innovation list of the top ten emerging technologies this list emphasizes on the technological developments which have the supremacy to transform industrieshellipglobal biosimilars market to be led by novartis by biologics which are typically inoculated or injected are formed in living entities making them more challenging and costly to manufacture than the usual pills contrived from chemicals observing that mockups are mostly identical to thehellipglobal thyroid gland disorder treatment market to grow steadilythe global thyroid gland disorder treatment market was worth us billion in  and is projected to reach a market value of us billion in  intensifying at a cagr of  from  to   thehellip highspeed data transmission and high volume needs propel fiber optic connectors market fiber optic connectors are a substantial fragment of the global telecommunication industry optical fibers are joined using fiber optic connectors which allow the light conduction between two consecutive optical fibers an additional im…extensive use of digital technologies for diagnostic applications to boost global optical imaging market the global optical imaging system market is predicted to reach us  billion by  it is expected to grow at a stable rate and will post a cagr of more than  in the coming years the growing market infiltration of digital …foremost trends in global pet care market the global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments it is estimated that the global pet care market will grow at a cagr o…china to review its food security laws china has arisen as the globe’s firmest developing economy in addition china brags about the biggest population pool in the world in recent times the one child policy in the republic was terminated this is anticipated to upsur…improving standards of living to boost global consumer durables market consumer durables is a cataloguing of consumer goods that are not essential to be bought very often as they are fashioned in a way so as to last for an extended period of time profits in the consumer durables sector were most profoundly… united states microbial identification market report  published jul        price us  onwards        pages  in this report the united states microbial identification market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx between  and  geographically this report splits the united states market into seven regions  the west  southwest  the middle atlantic  new england  the south  the midwest with sales volume  revenue value  market shar global electrophoresis sales market report  published jul        price us  onwards        pages  in this report the global electrophoresis market is valued at usd xx million in  and is expected to reach usd xx million by the end of  growing at a cagr of xx between  and  geographically this report split global into several key regions with sales k units  revenue million usd  market share and growth rate of electrophoresis for these regions from  to  forecast  covering  united states  china  europe  japa ephrin type b receptor  hepatoma transmembrane kinase or tyrosine protein kinase tyro or ephb or ec   pipeline review h  published jul        price us  onwards        pages  ephrin type b receptor  hepatoma transmembrane kinase or tyrosine protein kinase tyro or ephb or ec   pipeline review h  summary according to the recently published report ephrin type b receptor   pipeline review h  ephrin type b receptor  hepatoma transmembrane kinase or tyrosine protein kinase tyro or ephb or ec  pipeline target constitutes close to  molecules out of which approximately  molecules are developed by c tumor necrosis factor receptor superfamily member  glucocorticoid induced tumor necrosis factor receptor or activation inducible tnfr family receptor or glucocorticoid induced tnfr related protein or cd or tnfrsf  pipeline review h  published jul        price us  onwards        pages  tumor necrosis factor receptor superfamily member  glucocorticoid induced tumor necrosis factor receptor or activation inducible tnfr family receptor or glucocorticoid induced tnfr related protein or cd or tnfrsf  pipeline review h  summary tumor necrosis factor receptor superfamily member  glucocorticoid induced tumor necrosis factor receptor or activation inducible tnfr family receptor or glucocorticoid induced tnfr related protein or cd or t alpha c adrenergic receptor alpha  adrenergic receptor subtype c or alpha c adrenoreceptor or adrac  pipeline review h  published jul        price us  onwards        pages  alpha c adrenergic receptor alpha  adrenergic receptor subtype c or alpha c adrenoreceptor or adrac  pipeline review h  summary alpha c adrenergic receptor alpha  adrenergic receptor subtype c or alpha c adrenoreceptor or adrac  alphac adrenergic receptor or adrac is an alpha adrenergic receptor it mediates the catecholamineinduced inhibition of adenylate cyclase through the action of g proteins this receptor plays a critical role in re g protein coupled bile acid receptor  g protein coupled receptor gpcr or membrane type receptor for bile acids or hbg or gpr or gpbar  pipeline review h  published jul        price us  onwards        pages  g protein coupled bile acid receptor  g protein coupled receptor gpcr or membrane type receptor for bile acids or hbg or gpr or gpbar  pipeline review h  summary according to the recently published report g protein coupled bile acid receptor   pipeline review h  g protein coupled bile acid receptor  g protein coupled receptor gpcr or membrane type receptor for bile acids or hbg or gpr or gpbar pipeline target constitutes close metabotropic glutamate receptor  gprcd or mglur or grm  pipeline review h  published jul        price us  onwards        pages  metabotropic glutamate receptor  gprcd or mglur or grm  pipeline review h  summary metabotropic glutamate receptor  gprcd or mglur or grm pipeline target constitutes close to  molecules out of which approximately  molecules are developed by companies and remaining by the universitiesinstitutes the latest report metabotropic glutamate receptor   pipeline review h  outlays comprehensive information on the metabotropic glutamate recepto smoothened homolog protein gx or smo  pipeline review h  published jul        price us  onwards        pages  smoothened homolog protein gx or smo  pipeline review h  summary smoothened homolog protein gx or smo  smoothened homolog smo is a g proteincoupled receptor that probably associates with the patched protein ptch to transduce the hedgehogs proteins signal binding of sonic hedgehog shh to its receptor is thought to prevent normal inhibition by patched of smoothened smo it is required for the accumulation of kif and gli in the cilia  px purinoceptor  pz receptor or prx  pipeline review h  published jul        price us  onwards        pages  px purinoceptor  pz receptor or prx  pipeline review h  summary according to the recently published report px purinoceptor   pipeline review h  px purinoceptor  pz receptor or prx pipeline target constitutes close to  molecules out of which approximately  molecules are developed by companies px purinoceptor  pz receptor or prx  px purinoceptor  is a protein encoded by the prx gene it acts as receptor fo services value for money we believe in optimum utilization of available budget and resources while servicing our clients your market research requirements we keep the same approach in focus to help you get the best value for your s ever growing inventory ranging from the smallest feasible  required data datasheets data facts swot analysis company profiles etc to full research reports that help you make decisions our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than  niche sectors one stop solution need a custom research report on medical devices market require all available business intelligence on d printing industry exploring fb sector of a particular countryregion rnrmarketresearchcom is your onestopsolution to all market intelligence needs we not only offer custom research and consulting services we also bundle reports to meet your needs and help you fetch the data analysis you require for your business dedicated client engagement not limited to only finding relevant reports for you our client engagement team dedicates its efforts to understand your business need and accordingly maps available research data to help you move forward call your client engagement executive any time of your day and get your questions answered in order to make the correct business decision saving time and efforts simply share your research requirement details with us and let us do all the hard work to find required intelligence for you when you add up our one stop solution and dedicated client engagement services mentioned above you obviously know the time and effort saving you do by working with us payment flexibility working with fortune  organizations we understand the importance of being flexible for payments share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done postpurchase research support have questions after reading a report  datasheet bought through us not sure about the methodology used for data available in the research talk to us  share your questions with us and if required we will connect you with the analystsauthors of the reports and ensure you get satisfactory answers for the same need more data  analysis  reports on the topic of your researchproject the rnrmarketresearchcom team is here for you x to support you with your postpurchase requirements subscription offers  packages get in touch with us for more details  salesrnrmarketresearchcom       ad hoc pay  as  you  go  bucket subscriptions fixed cost for of reports customize  personalize as per your needs avail upto  discount on below publisher reports azoth analytics technavio biotechnology market research reports on market size and competitive analysis advanced search     salesrnrmarketresearchcom search market research reports market research assistance salesrnrmarketresearchcomon the web refine resultby datelast monthlast  monthslast  monthslast yearlast  years by price  home     life sciences    biotechnology biotechnology market research reports biotechnology the branch of applied biology that uses biological processes for medicineengineering technology industrial and other purposes the biotechnology uses in major areas including cloning reproductive cloning therapeutic cloning environmental biotechnology genetic engineering recombinant dna tissue engineering and pharmaceutical manufacturing the biotechnology market is mainly driven by favorable government initiatives increasing economic conditions easily accessibility of funding for rd increasing use of biotechnology in medical sciences and agriculture the global biotechnology industry is moulded by growth of flexible clinical trial designs healthcare reform legislation growing use of healthcare infrastructure medical device and pharmaceutical taxes and greater involvement of private companies in biotechnology market the market is also registerd growth in mergers and acquisitions followed by patent expiration of various blockbuster drugs and launview more biotechnology the branch of applied biology that uses biological processes for medicineengineering technology industrial and other purposes the biotechnology uses in major areas including cloning reproductive cloning therapeutic cloning environmental biotechnology genetic engineering recombinant dna tissue engineering and pharmaceutical manufacturing the biotechnology market is mainly driven by favorable government initiatives increasing economic conditions easily accessibility of funding for rd increasing use of biotechnology in medical sciences and agriculture the global biotechnology industry is moulded by growth of flexible clinical trial designs healthcare reform legislation growing use of healthcare infrastructure medical device and pharmaceutical taxes and greater involvement of private companies in biotechnology market the market is also registerd growth in mergers and acquisitions followed by patent expiration of various blockbuster drugs and launching of newer healthcare regulations the small companies attempt to divest their operation or signed the licensing collaborations and partnerships with the larger companies the biotechnology industry is shaped by human health followed by agriculture food industrial applications and environmental sciences the investments are made largely in discovery of new drugs and therapies including cardiology oncology diabetes hormone treatment antiviral antibody anemia and inflammation the market is led by us followed by advanced european countries such as uk france spain and germany and developing countries particularly india and china india and china rising as central markets for biotech drugs due to low cost of investment and ample talent pool also the market is facing several problems such as the smaller companies continue to face problems in raising funds for rd purposes and poor patent protection for biotech drug makersview less biochemicalenzymebiomaterialsdna sequencingcell culturestem cellbiopharmaceuticalwound caredrug discoverymicroarraybiomarkerstissue engineeringrnai technologyproteomicantibody technologymolecular biologygene therapyagriculture biotechnologygenomicnanomedicineindustrial biotechnologybioinformaticsgenetic engineeringinformaticantisense technologyenvironmental biotechnology biotechnology market research reports titlepublishedprice global hemicellulose market professional survey report by qyresearch group s in global market with production price revenue and market share for each manufacturer covering  novozymes  dupont  ab enzymes  dsm by types the market can be split into  polyxylose jul global protein hydrolysis enzymes market professional survey report by qyresearch group manufacturers in global market with production price revenue and market share for each manufacturer covering  novozymes  royal dsm  ab enzymes  dupont  solvay enzymes  amano enzymes  advancjul emea europe middle east and africa marine biotechnology market report by qyresearch group les k units  revenue million usd  market share and growth rate of marine biotechnology for these regions from  to  forecast  europe germany france uk russia italy and benelux  middle east saudi arabia israejul united states advanced wound care products market report by qyresearch group regions  the west  southwest  the middle atlantic  new england  the south  the midwest with sales volume  revenue value  market share and growth rate of advanced wound care prodjul global fetal bovine serum sales market report by qyresearch group   revenue million usd  market share and growth rate of fetal bovine serum for these regions from  to  forecast  covering  united states  china  europe  japan  southeast asia  indiajul global electrophoresis sales market report by qyresearch group revenue million usd  market share and growth rate of electrophoresis for these regions from  to  forecast  covering  united states  china  europe  japan  southeast asia  india jul global and china marine biotechnology industry professional market report by qyresearch group this report focus chinese market it covers details players regions product type and other details as following key players marinova neb biotechmarine glycomar marine biotech jul north america reverse transcriptase market by manufacturers countries type and application forecast to by global info research scriptase drives the opposite way in molecular processes in cells converting rna back to dna scope of the report this report focuses on the reverse transcriptase in north america market especially in united states canada anjul united states microbial identification market report by qyresearch group ions  the west  southwest  the middle atlantic  new england  the south  the midwest with sales volume  revenue value  market share and growth rate of microbial identification in jul emea europe middle east and africa glassionomer cement market report by qyresearch group les k mt  revenue million usd  market share and growth rate of glassionomer cement for these regions from  to  forecast  europe germany france uk russia italy and benelux  middle east saudi arabia israel jul                 next » avail upto  discount on below publisher reports azoth analytics technavio oncobiologics inc competitors  nasdaqcom hot topics etfs  smart portfolio  currencies  online broker center search home  quotes  onsiw  competitors oncobiologics inc competitors onsiw        get onsiw alerts delayed  data as of jul    et    find a broker to begin trading onsiw now exchangenasdaq industry health care community rating view    onsiw real time onsiw     edit symbol list symbol lookup real time nls trade reporting flashquotes infoquotes summary quote charts interactive charts premarket charts after hours charts revenue  eps summary company financials  view competitors  short interest company news press releases company news press releases sentiment analyst stock research stock report sec filings  holdingsinsider summary  institutional holdings  insider form  equity options premarket quotes after hours quotes company research  stockconsultant stock comparison  guru analysis annual report historical quotes call transcripts dividend history lynch analysis graham analysis validea momentum analysis fool analysis dreman analysis zweig analysis fisher analysis oshaughnessy analysis etf detail etf profile comparison charts symbol list views flashquotes infoquotes stock details summary quote realtime quote after hours quote premarket quote historical quote option chain charts basic chart interactive chart company news company headlines press releases market stream stock analysis analyst research guru analysis stock report competitors stock consultant stock comparison fundamentals call transcripts annual report income statement revenueeps sec filings short interest dividend history holdings ownership summary institutional holdings insiderssec form  closex edit symbol list enter up to  symbols separated by commas or spaces in the text box below these symbols will be available during your session for use on applicable pages go now clear list dont know the stock symbol use the symbol lookup tool alphabetize the sort order of my symbols closex   symbol lookup closex investing just got easier… sign up now to become a nasdaqcom member and begin receiving instant notifications when key events occur that affect the stocks you follow access now  save stocks competitor industry biotechnology biological products no diagnostic substances oncobiologics inc companyname ▲ symbol market lastsale netchange volume todays high  low  weeks high  low p  e ratio market cap acceleron pharma incxlrn nasdaqgm    ▼        ne  acorda therapeutics incacor nasdaqgs    ▼        ne  adaptimmune therapeutics plcadap nasdaqgs    ▼        ne  adma biologics incadma nasdaqcm    ▼        ne  adverum biotechnologies incadvm nasdaqgm    ▼        ne  aerie pharmaceuticals incaeri nasdaqgm    ▼        ne  aevi genomic medicine incgnmx nasdaqgm    ▼        ne  agenus incagen nasdaqcm    ▼        ne  amgen incamgn nasdaqgs    ▼          ampliphi biosciences corporationaphb amex    ▼        ne  apollo endosurgery incapen nasdaqgm   unch        ne  applied genetic technologies corporationagtc nasdaqgm    ▼          aptose biosciences incapto nasdaqcm    ▼        ne  argenx seargx nasdaqgs    ▼        ne  asterias biotherapeutics incast amex    ▼        ne  atara biotherapeutics incatra nasdaqgs    ▼        ne  atyr pharma inclife nasdaqgs   unch        ne  audentes therapeutics incbold nasdaqgm    ▼        ne  avexis incavxs nasdaqgs    ▼        ne  aviragen therapeutics incavir nasdaqgs    ▼        ne  biocryst pharmaceuticals incbcrx nasdaqgs    ▲        ne  biogen incbiib nasdaqgs    ▼          biondvax pharmaceuticals ltdbvxv nasdaqcm    ▼        ne  biondvax pharmaceuticals ltdbvxvw nasdaqcm    ▼        ne  biotechne corptech nasdaqgs    ▼           first previousnext last  closex edit favorites enter up to  symbols separated by commas or spaces in the text box below these symbols will be available during your session for use on applicable pages update clear list closex customize your nasdaqcom experience background color selector select the background color of your choice  black  slate gray  light gray  gray blue quote search select a default target page for your quote search  realtime  after hours  premarket  news  flash quote  summary quote  interactive charts  default setting please note that once you make your selection it will apply to all future visits to nasdaqcom if at any time you are interested in reverting to our default settings please select default setting above if you have any questions or encounter any issues in changing your default settings please email isfeedbacknasdaqcom closex please confirm your selection you have selected to change your default setting for the quote search this will now be your default target page unless you change your configuration again or you delete your cookies are you sure you want to change your settings yes no closex please disable your ad blocker or update your settings to ensure that javascript and cookies are enabled so that we can continue to provide you with the firstrate market news and data youve come to expect from us closex oncobiologics inc product pipeline review  is released by idata insights  issuu issuu company logo issuu explore categories arts  entertainment style  fashion home  garden business travel education see all categories collections top picks generators hygge feminism zines makers find more plans  pricing community help  support about issuu publisher plans close categories arts  entertainment style  fashion home  garden business travel education see all categories collections top picks generators hygge feminism zines makers find more plans  pricing community help  support about issuu sign up sign in sign in onsnasdaq gm stock quote  oncobiologics inc  bloomberg markets error could not add to watchlist x  watchlist oncobiologics inc onsus nasdaq gm usd   as of  pm edt  open  day range    volume  previous close  wk range     yr return  before its here its on the bloomberg terminal learn more open  day range    volume  previous close  wk range     yr return  ytd return  current pe ratio ttm  earnings per share usd ttm  market cap m usd  shares outstanding m  pricesales ttm  dividend indicated gross yield  sector health care  price change  industry pharmaceuticals biotechnology  life sciences  price change  related videos there are currently no related videos for this ticker please check back later company news press releases there are currently no news stories for this ticker please check back later  oncobiologics closes on final portion of  million senior secured note and warrant offering  bone metastasis therapeutic pipeline review h  research report now available at rnrmarketresearchcom  oncobiologics to present at the world biosimilar congress   oncobiologics secures additional funding there are currently no press releases for this ticker please check back later profile oncobiologics inc operates as a clinicalstage biopharmaceutical company the company engages in identifying developing manufacturing and commercializing complex biosimilar therapeutics oncobiologics focuses on monoclonal antibodies in the disease areas of immunology and oncology aspects address  clarke drivecranbury nj united states phone  website wwwoncobiologicscom executives board members pankaj mohan chairmanpresidentceofounder lawrence a kenyon cfosecretary kenneth m bahrt chief medical officer scott a gangloff senior vpdev  manufacturing stephen j mcandrew senior vpbusiness strategy show more oncobiologics nasdaqonsiu stock price news  analysis oncobiologics company profile nasdaqonsiu company profile analyst ratings earnings history earnings estimates dividend history insider trade headlines social media chart about oncobiologics nasdaqonsiu oncobiologics inc is a clinicalstage biopharmaceutical company the company is focused on identifying developing manufacturing and commercializing biosimilar therapeutics it is focused on monoclonal antibodies mabs in the disease areas of immunology and oncology the company offers biosymphony platform the company has identified approximately eight biosimilar product candidates of which two product candidates are ons and ons ons is an adalimumab humira biosimilar the company has initiated phase iii preparatory activities for ons its second product candidate ons is a bevacizumab avastin biosimilar the companys other preclinical product candidate ons a trastuzumab herceptin biosimilar interferes with the human epidermal growth factor receptor  her ons is a biosimilar to denosumab proliaxgeva which is a human mab its other biosimilar product ons is a biosimilar to cetuximab erbitux industry sector and symbol sector healthcare industry biotechnology  medical research  nec subindustry na symbol nasdaqonsiu cusip na web oncobiologicscom average prices day moving avg  day moving avg  week range    petrailing pe ratio naforeward pe ratio pe growth  profitabilitynet margins miscaverage volume  shs   frequently asked questions for oncobiologics nasdaqonsiu what is oncobiologics stock symbol oncobiologics trades on the nasdaq under the ticker symbol onsiu who are some of oncobiologics key competitors some companies that are related to oncobiologics include incyte corporation incy quintiles transitional holdings q alkermes plc alks seattle genetics sgen qiagen nv qgen alnylam pharmaceuticals alny ionis pharmaceuticals ions united therapeutics corporation uthr icon plc iclr pra health sciences prah charles river laboratories international crl parexel international corporation prxl exact sciences corporation exas biotechne corp tech galapagos nv glpg portola pharmaceuticals ptla acadia pharmaceuticals acad and nektar therapeutics nktr who are oncobiologics key executives oncobiologics management team includes the folowing people pankaj mohan phd chairman of the board president chief executive officerlawrence a kenyon chief financial officer secretaryscott gangloff senior vice president  process development and manufacturingstephen j mcandrew phd senior vice president  business strategy  developmentkenneth m bahrt md chief medical officer when did oncobiologics ipo onsiu raised  million in an initial public offering on friday may th  the company issued  shares at a price of  per share jefferies and barclays served as the underwriters for the ipo and cantor fitzgerald  co was comanager how do i buy oncobiologics stock shares of oncobiologics can be purchased through any online brokerage account popular online brokerages include vanguard brokerage services td ameritrade etrade scottrade fidelity and charles schwab what is oncobiologics stock price today one share of oncobiologics stock can currently be purchased for approximately  marketbeat community rating for oncobiologics nasdaq onsiucommunity ranking   out of    outperform votes   vote outperformunderperform votes   vote underperformtotal votes  marketbeats community ratings are surveys of what our community members think about oncobiologics and other stocks vote outperform if you believe the stock will outperform the sp  over the long term vote underperform if you believe the stock will underperform the sp  over the long term you may vote once every thirty days analyst ratings consensus ratings for oncobiologics nasdaqonsiu how are consensus ratings calculated marketbeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months since brokers often use different ratings systems each rating is normalized to a standardized rating score of  sell  hold  buy or  strong buy consensus ratings scores are calculated using the mean average of the number of normalized sell hold buy and strong buy ratings each stocks consensus rating is derived from its calculated consensus ratings score   sell   hold   buy   strong buy marketbeats consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve monthsmarketbeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and marketbeat has received a report that coverage was dropped ratings from certain research firms that issue ratings using purely quantitative methods such as zacks vetr and valuengine are not included in consensus calculations marketbeats consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available dataratings breakdown  hold ratingconsensus ratinghold score consensus price target na analysts ratings history for oncobiologics nasdaqonsiu show only the most recent rating from each brokerage all ratings for this stock datefirmactionratingprice targetimpact on share pricedetailsjefferies group llcdowngradebuy  holdnacantor fitzgeraldinitiated coveragebuynabarclays plcinitiated coverageoverweightnadata available from  forward earnings earnings history for oncobiologics nasdaqonsiuno earnings announcements for this company have been tracked by marketbeatcom estimates earnings estimates for oncobiologics nasdaqonsiucurrent year eps consensus estimate  epsnext year eps consensus estimate  eps dividends dividend history for oncobiologics nasdaqonsiuno dividend announcements for this company have been tracked by marketbeatcom insider trades insider trading history for oncobiologics nasdaqonsiuno insider trades for this company have been tracked by marketbeatcom headlines headline trends for oncobiologics nasdaqonsiu latest headlines for oncobiologics nasdaqonsiu source all sources trusted sources marketbeatcom bloomberg marketwatch motley fool nasdaq reuters seeking alpha the street the wall street journal yahoo finance dateheadlinejefferies has  growth stocks to buy with big upside and catalyst potentialwallstcom  june  at  am analyst stocks under  with massive upside potentialwallstcom  june  at  amoncobiologics inc files sec form k other events financial statements and exhibitsbizyahoocom  june  at  pm pm oncobiologics announces the separation of units issued in its ipofinanceyahoocom  june  at  pmoncobiologics announces separation of units trading of common stock and warrantsfinanceyahoocom  june  at  pmcoverage initiated on oncobiologics by barclaysfinanceyahoocom  june  at  amoncobiologics inc files sec form k entry into a material definitive agreement unregistered sale of equity securbizyahoocom  may  at  pm social chart oncobiologics onsiu chart for thursday july   this page was last updated on  by marketbeatcom staff market report oncobiologics inc  product pipeline review   about us • publishers • contact us • cart login  register all industries business  finance  business  financial services  insurance  marketing consumer  food  beverages  consumer goods  food  retailing healthcare  biotechnology  healthcare  medical devices  pharmaceuticals heavy industry  construction  energy  manufacturing  materials  transportation internet  media  ebusiness  internet  media  publishing public sector  defense  education  government telecom  computing  computer technology  fixed networks  software  wireless companycountry reports  company reports  country reports  regional reports   processing oncobiologics inc  product pipeline review   dec    global markets direct   pages  usd  click here to open the popup youve added the following report to your cartclose cart summary total items subtotal      report summary table of contents request details related global markets directs oncobiologics inc  product pipeline review   provides an overview of the oncobiologics incs pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of oncobiologics incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasereport scopethe report provides brief overview of oncobiologics inc including business description key information and facts and its locations and subsidiariesthe report reviews current pipeline of oncobiologics incs human therapeutic division and enlists all their major and minor projectsthe report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestonesspecial feature on outlicensed and partnered product portfoliothe report summarizes all the dormant and discontinued pipeline projectslatest company statementlatest news and deals relating to the oncobiologics incs pipeline productsreasons to get this reportevaluate oncobiologics incs strategic position with total access to detailed information on its product pipelineassess the growth potential of oncobiologics inc in its therapy areas of focusidentify new drug targets and therapeutic classes in the oncobiologics incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areasexploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gapsdevelop strategic initiatives by understanding the focus areas of oncobiologics inc and exploit collaboration and partnership opportunitiesidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantageplan mergers and acquisitions effectively by identifying the most promising pipeline of oncobiologics incdevelop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeexplore the dormant and discontinued projects of oncobiologics inc and identify potential opportunities in those areasavoid intellectual property rights related issues table of contentstable of contents list of tables list of figures oncobiologics inc snapshot oncobiologics inc overview key information key facts oncobiologics inc  research and development overview key therapeutic areas oncobiologics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy oncobiologics inc  pipeline products glance oncobiologics inc  clinical stage pipeline products phase i productscombination treatment modalities oncobiologics inc  early stage pipeline products preclinical productscombination treatment modalities oncobiologics inc  drug profiles adalimumab biosimilar product description mechanism of action rd progress bevacizumab biosimilar product description mechanism of action rd progress cetuximab biosimilar product description mechanism of action rd progress denosumab biosimilar product description mechanism of action rd progress golimumab biosimilar product description mechanism of action rd progress tocilizumab biosimilar product description mechanism of action rd progress trastuzumab biosimilar product description mechanism of action rd progress ustekinumab biosimilar product description mechanism of action rd progress oncobiologics inc  pipeline analysis oncobiologics inc  pipeline products by target oncobiologics inc  pipeline products by route of administration oncobiologics inc  pipeline products by molecule type oncobiologics inc  pipeline products by mechanism of action oncobiologics inc  recent pipeline updates oncobiologics inc  dormant projects oncobiologics inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablesoncobiologics inc key information oncobiologics inc key facts oncobiologics inc  pipeline by indication  oncobiologics inc  pipeline by stage of development  oncobiologics inc  monotherapy products in pipeline  oncobiologics inc  phase i  oncobiologics inc  preclinical  oncobiologics inc  pipeline by target  oncobiologics inc  pipeline by route of administration  oncobiologics inc  pipeline by molecule type  oncobiologics inc  pipeline products by mechanism of action  oncobiologics inc  recent pipeline updates  oncobiologics inc  dormant developmental projects list of figuresoncobiologics inc  pipeline by top  indication  oncobiologics inc  pipeline by stage of development  oncobiologics inc  monotherapy products in pipeline  oncobiologics inc  pipeline by top  target  oncobiologics inc  pipeline by top  route of administration  oncobiologics inc  pipeline by top  molecule type  oncobiologics inc  pipeline products by top  mechanism of action   this report does not have a list of companies mentioned available this report does not have a press release associated with it order today format pdf  usd license single user delivery by email   business day the fast market research advantage only the best all of our research is sourced from the most trusted and established global analysts and consultancies client focused from startups to multinationals we focus on providing the right research to our diverse client base shop securely our usbased customer service team and ecommerce systems adhere to the highest data security standards industryleading customer support individualized assistance from our expert staff is never more than an email or phone call away best price guarantee we are committed to providing the best research at the lowest cost we will match any published price for the same report guaranteed easy ordering once you’ve found the right report click ‘order now’ and complete the checkout process using any major credit card check or wirebank transferneed multiuser or enterprise license pricing contact us for a custom quote about the publisher global markets direct is a leading provider of global business intelligence and market analysis it publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industryspecific information publisher details privacy policy  terms of use  flashalerts copyright copy  fast market research inc